
Cimetidine
Description
Historical Context of Histamine H2-Receptor Antagonist Discovery and Development
The journey to discovering histamine H₂-receptor antagonists began with recognizing that histamine played a role in stimulating gastric acid secretion. However, conventional antihistamines, known to block histamine's effects in allergic reactions (mediated by what were later termed H₁ receptors), had no impact on acid production. This observation was a key driver in the hypothesis of distinct histamine receptor subtypes.
In the late 1940s, observations indicated that some actions of histamine, such as increasing heart rate and stimulating gastric acid secretion, were not inhibited by classical antihistamines like mepyramine. karger.com This led researchers, notably A.S. Dale and H.W. Dudley, and later Ash and Schild in 1966, to propose the existence of at least two different types of histamine receptors. karger.comnews-medical.net They designated the receptor blocked by traditional antihistamines as H₁, and the receptor mediating effects like gastric acid secretion as H₂. This conceptualization was crucial, as it provided a theoretical basis for seeking compounds that could selectively block the H₂ receptor without affecting the H₁ receptor. acs.org
The development of cimetidine by a team at Smith Kline & French (SK&F) Laboratories, led by Sir James Black, is considered a classic example of rational drug design. acs.orgwikipedia.orgslideshare.netstereoelectronics.org Unlike the traditional approach of screening natural products or synthesizing numerous analogs of existing active compounds without a clear understanding of the biological target, the SK&F team started with a specific biological hypothesis: that blocking the hypothetical H₂ receptor would inhibit gastric acid secretion. acs.orguomustansiriyah.edu.iq
Beginning with the structure of histamine, the endogenous ligand for these receptors, the researchers systematically modified the molecule to identify structural features required for receptor binding and activation (agonism) versus blockade (antagonism). wikipedia.orgwikipedia.org Early work involved synthesizing hundreds of modified histamine analogs. wikipedia.org A breakthrough came with the identification of Nα-guanylhistamine, a partial H₂ receptor antagonist. wikipedia.org This provided a lead structure that could be further refined. Subsequent modifications led to burimamide, the first compound identified as a specific competitive antagonist at the H₂ receptor, approximately 100 times more potent than Nα-guanylhistamine. wikipedia.org Burimamide's activity in blocking histamine's effects on gastric acid secretion in experimental models provided pharmacological evidence for the existence of the H₂ receptor. karger.comuniroma1.it
However, burimamide was not sufficiently potent for oral administration. wikipedia.orgwikipedia.org Further structural modifications, guided by the developing understanding of the H₂ receptor's likely chemical environment and the principles of quantitative structure-activity relationships (QSAR), led to metiamide. wikipedia.orgwikipedia.org Metiamide was more potent than burimamide and showed promising clinical effects in inhibiting gastric acid secretion. wikipedia.orguniroma1.it Unfortunately, metiamide was associated with toxicity, specifically agranulocytosis, attributed to its thiourea group. wikipedia.org This necessitated further refinement of the structure, leading to the synthesis of this compound, where the thiourea group was replaced with a cyanoguanidine moiety. acs.orgwikipedia.org this compound retained the desired H₂ receptor blocking activity while mitigating the toxicity observed with metiamide. wikipedia.orguniroma1.it This iterative process of design, synthesis, and testing, guided by a rational understanding of the target receptor, was fundamental to this compound's successful development. acs.orguomustansiriyah.edu.iq
Conceptualization of Distinct Histamine Receptor Subtypes
Evolution of this compound's Significance in Pharmacological and Medical Research
This compound's introduction in the late 1970s marked a paradigm shift in the treatment of peptic ulcer disease, which had previously relied heavily on surgery or less effective antacid therapies. acs.orguniroma1.it By effectively inhibiting gastric acid secretion, this compound promoted ulcer healing and dramatically reduced the need for surgical intervention. acs.org Its success as the first widely available and effective treatment for these common and often debilitating conditions quickly made it a "blockbuster" drug, achieving significant sales worldwide. stereoelectronics.orgwikipedia.orgencyclopedia.pub
Beyond its immediate clinical impact, this compound's development and success had profound implications for pharmacological and medical research. It validated the power of the rational drug design approach, demonstrating that a systematic, target-driven strategy could lead to the discovery of highly effective therapeutic agents. acs.orgslideshare.netstereoelectronics.org This success encouraged the pharmaceutical industry to invest further in understanding molecular targets and designing drugs based on this knowledge.
This compound also served as the prototypical H₂ receptor antagonist, paving the way for the development of subsequent H₂ blockers such as ranitidine, famotidine, and nizatidine. wikipedia.orgwikipedia.orgencyclopedia.pubnih.gov These later compounds were developed using similar rational design principles, often aiming for improved potency, longer duration of action, or better safety profiles based on the foundational knowledge gained from this compound. wikipedia.orgencyclopedia.pub While proton pump inhibitors (PPIs) have largely superseded H₂ antagonists as the preferred treatment for many acid-related disorders due to their greater efficacy in suppressing acid production, the research and clinical success of this compound were instrumental in transforming the understanding and management of these conditions. wikipedia.orgencyclopedia.pubnih.gov The work on histamine receptors and the development of this compound were recognized with the Nobel Prize in Physiology or Medicine awarded to Sir James Black in 1988. karger.comwikipedia.orgnih.govnih.govbritannica.com
Here is a conceptual representation of how data on receptor affinity might have been presented during the development process:
Compound | Activity Type | H₂ Receptor Affinity (e.g., pA₂) | Relative Potency (vs. Histamine or Nα-guanylhistamine) | Notes |
Histamine | Agonist | - | - | Endogenous ligand |
Nα-guanylhistamine | Partial Antagonist | Lower | Partial antagonism | Initial lead compound |
Burimamide | Antagonist | Higher | ~100x Nα-guanylhistamine wikipedia.org | First specific H₂ antagonist karger.comuniroma1.it |
Metiamide | Antagonist | Higher than Burimamide | Higher than Burimamide uniroma1.it | More potent, but toxic wikipedia.org |
This compound | Antagonist | Higher than Metiamide (in vivo) | Higher than Metiamide (in vivo) uniroma1.it | Improved safety profile wikipedia.orguniroma1.it |
Note: Specific pA₂ values would vary depending on the experimental system used.
This table illustrates the type of comparative pharmacological data that underpinned the rational design process, demonstrating the stepwise improvement in H₂ receptor antagonist activity from initial leads to the final drug candidate, this compound.
Properties
IUPAC Name |
1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine | |
---|---|---|
Source | PubChem | |
URL | https://pubchem.ncbi.nlm.nih.gov | |
Description | Data deposited in or computed by PubChem | |
InChI |
InChI=1S/C10H16N6S/c1-8-9(16-7-15-8)5-17-4-3-13-10(12-2)14-6-11/h7H,3-5H2,1-2H3,(H,15,16)(H2,12,13,14) | |
Source | PubChem | |
URL | https://pubchem.ncbi.nlm.nih.gov | |
Description | Data deposited in or computed by PubChem | |
InChI Key |
AQIXAKUUQRKLND-UHFFFAOYSA-N | |
Source | PubChem | |
URL | https://pubchem.ncbi.nlm.nih.gov | |
Description | Data deposited in or computed by PubChem | |
Canonical SMILES |
CC1=C(N=CN1)CSCCNC(=NC)NC#N | |
Source | PubChem | |
URL | https://pubchem.ncbi.nlm.nih.gov | |
Description | Data deposited in or computed by PubChem | |
Molecular Formula |
C10H16N6S | |
Record name | CIMETIDINE | |
Source | CAMEO Chemicals | |
URL | https://cameochemicals.noaa.gov/chemical/20034 | |
Description | CAMEO Chemicals is a chemical database designed for people who are involved in hazardous material incident response and planning. CAMEO Chemicals contains a library with thousands of datasheets containing response-related information and recommendations for hazardous materials that are commonly transported, used, or stored in the United States. CAMEO Chemicals was developed by the National Oceanic and Atmospheric Administration's Office of Response and Restoration in partnership with the Environmental Protection Agency's Office of Emergency Management. | |
Explanation | CAMEO Chemicals and all other CAMEO products are available at no charge to those organizations and individuals (recipients) responsible for the safe handling of chemicals. However, some of the chemical data itself is subject to the copyright restrictions of the companies or organizations that provided the data. | |
Source | PubChem | |
URL | https://pubchem.ncbi.nlm.nih.gov | |
Description | Data deposited in or computed by PubChem | |
DSSTOX Substance ID |
DTXSID4020329 | |
Record name | Cimetidine | |
Source | EPA DSSTox | |
URL | https://comptox.epa.gov/dashboard/DTXSID4020329 | |
Description | DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology. | |
Molecular Weight |
252.34 g/mol | |
Source | PubChem | |
URL | https://pubchem.ncbi.nlm.nih.gov | |
Description | Data deposited in or computed by PubChem | |
Physical Description |
Cimetidine appears as white crystals with a slight sulfur-mercaptan odor. (NTP, 1992), Solid | |
Record name | CIMETIDINE | |
Source | CAMEO Chemicals | |
URL | https://cameochemicals.noaa.gov/chemical/20034 | |
Description | CAMEO Chemicals is a chemical database designed for people who are involved in hazardous material incident response and planning. CAMEO Chemicals contains a library with thousands of datasheets containing response-related information and recommendations for hazardous materials that are commonly transported, used, or stored in the United States. CAMEO Chemicals was developed by the National Oceanic and Atmospheric Administration's Office of Response and Restoration in partnership with the Environmental Protection Agency's Office of Emergency Management. | |
Explanation | CAMEO Chemicals and all other CAMEO products are available at no charge to those organizations and individuals (recipients) responsible for the safe handling of chemicals. However, some of the chemical data itself is subject to the copyright restrictions of the companies or organizations that provided the data. | |
Record name | Cimetidine | |
Source | Human Metabolome Database (HMDB) | |
URL | http://www.hmdb.ca/metabolites/HMDB0014644 | |
Description | The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body. | |
Explanation | HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications. | |
Solubility |
5 mg/mL at 68 °F (NTP, 1992), IN WATER AT 37 °C: 1.14%; SOLUBILITY INCR BY DIL HYDROCHLORIC ACID, Soluble in alcohol, 8.16e-01 g/L | |
Record name | CIMETIDINE | |
Source | CAMEO Chemicals | |
URL | https://cameochemicals.noaa.gov/chemical/20034 | |
Description | CAMEO Chemicals is a chemical database designed for people who are involved in hazardous material incident response and planning. CAMEO Chemicals contains a library with thousands of datasheets containing response-related information and recommendations for hazardous materials that are commonly transported, used, or stored in the United States. CAMEO Chemicals was developed by the National Oceanic and Atmospheric Administration's Office of Response and Restoration in partnership with the Environmental Protection Agency's Office of Emergency Management. | |
Explanation | CAMEO Chemicals and all other CAMEO products are available at no charge to those organizations and individuals (recipients) responsible for the safe handling of chemicals. However, some of the chemical data itself is subject to the copyright restrictions of the companies or organizations that provided the data. | |
Record name | Cimetidine | |
Source | DrugBank | |
URL | https://www.drugbank.ca/drugs/DB00501 | |
Description | The DrugBank database is a unique bioinformatics and cheminformatics resource that combines detailed drug (i.e. chemical, pharmacological and pharmaceutical) data with comprehensive drug target (i.e. sequence, structure, and pathway) information. | |
Explanation | Creative Common's Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/legalcode) | |
Record name | CIMETIDINE | |
Source | Hazardous Substances Data Bank (HSDB) | |
URL | https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3917 | |
Description | The Hazardous Substances Data Bank (HSDB) is a toxicology database that focuses on the toxicology of potentially hazardous chemicals. It provides information on human exposure, industrial hygiene, emergency handling procedures, environmental fate, regulatory requirements, nanomaterials, and related areas. The information in HSDB has been assessed by a Scientific Review Panel. | |
Record name | Cimetidine | |
Source | Human Metabolome Database (HMDB) | |
URL | http://www.hmdb.ca/metabolites/HMDB0014644 | |
Description | The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body. | |
Explanation | HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications. | |
Color/Form |
Crystals | |
CAS No. |
51481-61-9 | |
Record name | CIMETIDINE | |
Source | CAMEO Chemicals | |
URL | https://cameochemicals.noaa.gov/chemical/20034 | |
Description | CAMEO Chemicals is a chemical database designed for people who are involved in hazardous material incident response and planning. CAMEO Chemicals contains a library with thousands of datasheets containing response-related information and recommendations for hazardous materials that are commonly transported, used, or stored in the United States. CAMEO Chemicals was developed by the National Oceanic and Atmospheric Administration's Office of Response and Restoration in partnership with the Environmental Protection Agency's Office of Emergency Management. | |
Explanation | CAMEO Chemicals and all other CAMEO products are available at no charge to those organizations and individuals (recipients) responsible for the safe handling of chemicals. However, some of the chemical data itself is subject to the copyright restrictions of the companies or organizations that provided the data. | |
Record name | Cimetidine | |
Source | CAS Common Chemistry | |
URL | https://commonchemistry.cas.org/detail?cas_rn=51481-61-9 | |
Description | CAS Common Chemistry is an open community resource for accessing chemical information. Nearly 500,000 chemical substances from CAS REGISTRY cover areas of community interest, including common and frequently regulated chemicals, and those relevant to high school and undergraduate chemistry classes. This chemical information, curated by our expert scientists, is provided in alignment with our mission as a division of the American Chemical Society. | |
Explanation | The data from CAS Common Chemistry is provided under a CC-BY-NC 4.0 license, unless otherwise stated. | |
Record name | Cimetidine [USAN:USP:INN:BAN:JAN] | |
Source | ChemIDplus | |
URL | https://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&sourceid=0051481619 | |
Description | ChemIDplus is a free, web search system that provides access to the structure and nomenclature authority files used for the identification of chemical substances cited in National Library of Medicine (NLM) databases, including the TOXNET system. | |
Record name | Cimetidine | |
Source | DrugBank | |
URL | https://www.drugbank.ca/drugs/DB00501 | |
Description | The DrugBank database is a unique bioinformatics and cheminformatics resource that combines detailed drug (i.e. chemical, pharmacological and pharmaceutical) data with comprehensive drug target (i.e. sequence, structure, and pathway) information. | |
Explanation | Creative Common's Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/legalcode) | |
Record name | cimetidine | |
Source | DTP/NCI | |
URL | https://dtp.cancer.gov/dtpstandard/servlet/dwindex?searchtype=NSC&outputformat=html&searchlist=757428 | |
Description | The NCI Development Therapeutics Program (DTP) provides services and resources to the academic and private-sector research communities worldwide to facilitate the discovery and development of new cancer therapeutic agents. | |
Explanation | Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source. | |
Record name | cimetidine | |
Source | DTP/NCI | |
URL | https://dtp.cancer.gov/dtpstandard/servlet/dwindex?searchtype=NSC&outputformat=html&searchlist=335308 | |
Description | The NCI Development Therapeutics Program (DTP) provides services and resources to the academic and private-sector research communities worldwide to facilitate the discovery and development of new cancer therapeutic agents. | |
Explanation | Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source. | |
Record name | Cimetidine | |
Source | EPA DSSTox | |
URL | https://comptox.epa.gov/dashboard/DTXSID4020329 | |
Description | DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology. | |
Record name | Cimetidine | |
Source | European Chemicals Agency (ECHA) | |
URL | https://echa.europa.eu/substance-information/-/substanceinfo/100.052.012 | |
Description | The European Chemicals Agency (ECHA) is an agency of the European Union which is the driving force among regulatory authorities in implementing the EU's groundbreaking chemicals legislation for the benefit of human health and the environment as well as for innovation and competitiveness. | |
Explanation | Use of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: "Source: European Chemicals Agency, http://echa.europa.eu/". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page. | |
Record name | CIMETIDINE | |
Source | FDA Global Substance Registration System (GSRS) | |
URL | https://gsrs.ncats.nih.gov/ginas/app/beta/substances/80061L1WGD | |
Description | The FDA Global Substance Registration System (GSRS) enables the efficient and accurate exchange of information on what substances are in regulated products. Instead of relying on names, which vary across regulatory domains, countries, and regions, the GSRS knowledge base makes it possible for substances to be defined by standardized, scientific descriptions. | |
Explanation | Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required. | |
Record name | CIMETIDINE | |
Source | Hazardous Substances Data Bank (HSDB) | |
URL | https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3917 | |
Description | The Hazardous Substances Data Bank (HSDB) is a toxicology database that focuses on the toxicology of potentially hazardous chemicals. It provides information on human exposure, industrial hygiene, emergency handling procedures, environmental fate, regulatory requirements, nanomaterials, and related areas. The information in HSDB has been assessed by a Scientific Review Panel. | |
Record name | Cimetidine | |
Source | Human Metabolome Database (HMDB) | |
URL | http://www.hmdb.ca/metabolites/HMDB0014644 | |
Description | The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body. | |
Explanation | HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications. | |
Melting Point |
284 to 290 °F (NTP, 1992), 141-143 °C, 142 °C | |
Record name | CIMETIDINE | |
Source | CAMEO Chemicals | |
URL | https://cameochemicals.noaa.gov/chemical/20034 | |
Description | CAMEO Chemicals is a chemical database designed for people who are involved in hazardous material incident response and planning. CAMEO Chemicals contains a library with thousands of datasheets containing response-related information and recommendations for hazardous materials that are commonly transported, used, or stored in the United States. CAMEO Chemicals was developed by the National Oceanic and Atmospheric Administration's Office of Response and Restoration in partnership with the Environmental Protection Agency's Office of Emergency Management. | |
Explanation | CAMEO Chemicals and all other CAMEO products are available at no charge to those organizations and individuals (recipients) responsible for the safe handling of chemicals. However, some of the chemical data itself is subject to the copyright restrictions of the companies or organizations that provided the data. | |
Record name | Cimetidine | |
Source | DrugBank | |
URL | https://www.drugbank.ca/drugs/DB00501 | |
Description | The DrugBank database is a unique bioinformatics and cheminformatics resource that combines detailed drug (i.e. chemical, pharmacological and pharmaceutical) data with comprehensive drug target (i.e. sequence, structure, and pathway) information. | |
Explanation | Creative Common's Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/legalcode) | |
Record name | CIMETIDINE | |
Source | Hazardous Substances Data Bank (HSDB) | |
URL | https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3917 | |
Description | The Hazardous Substances Data Bank (HSDB) is a toxicology database that focuses on the toxicology of potentially hazardous chemicals. It provides information on human exposure, industrial hygiene, emergency handling procedures, environmental fate, regulatory requirements, nanomaterials, and related areas. The information in HSDB has been assessed by a Scientific Review Panel. | |
Record name | Cimetidine | |
Source | Human Metabolome Database (HMDB) | |
URL | http://www.hmdb.ca/metabolites/HMDB0014644 | |
Description | The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body. | |
Explanation | HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications. | |
Molecular and Cellular Mechanisms of Cimetidine Action
Histamine H2 Receptor Antagonism: Detailed Mechanistic Insights
Cimetidine functions as a histamine H2 receptor antagonist, primarily impacting gastric acid secretion. wikipedia.orgdrugbank.compatsnap.comnih.govpediatriconcall.commedicaldialogues.in This antagonism is the basis for its use in conditions associated with excessive stomach acid. wikipedia.orgdrugbank.compatsnap.commedicaldialogues.in
Competitive Inhibition Dynamics at Gastric Parietal Cells
The primary mechanism by which this compound reduces gastric acid secretion is through competitive inhibition of histamine at the histamine H2 receptors located on the basolateral membrane of gastric parietal cells. drugbank.compatsnap.comnih.govpediatriconcall.commedicaldialogues.indroracle.ai Parietal cells are the cells responsible for producing and secreting hydrochloric acid in the stomach. patsnap.com Histamine, released from enterochromaffin-like (ECL) cells in the stomach, stimulates these H2 receptors, initiating a signaling cascade that leads to acid production. patsnap.com By competitively binding to these receptors, this compound blocks histamine's ability to bind and activate them. drugbank.compatsnap.comnih.govpediatriconcall.commedicaldialogues.indroracle.ai This competitive blockade reduces both basal and stimulated gastric acid secretion, as well as gastric volume and acidity. drugbank.commedicaldialogues.indroracle.ai Stimuli whose effects on acid secretion are inhibited by this compound include food, histamine, pentagastrin, caffeine, and insulin. droracle.ai
Molecular Interactions with H2 Receptors
At the molecular level, this compound's interaction with the histamine H2 receptor involves binding to specific sites on the receptor protein. This compound has been found to bind to the H2 receptor with a dissociation constant (Kd) of 42 nM. wikipedia.org Studies investigating the molecular basis of histamine interaction with the H2 receptor have identified key amino acid residues involved in ligand binding. For instance, Asp98 in the third transmembrane domain of the receptor is considered essential for histamine binding and action, likely interacting with the cationic amine moiety of histamine. nih.gov Asp186 is suggested to define H2 selectivity, while Thr190 is important for establishing the kinetics of histamine binding. nih.gov While these studies primarily focus on histamine binding, they provide context for the types of molecular interactions that antagonists like this compound would engage in at the same receptor site. Computational studies have also explored the importance of hydrogen bonding interactions for the binding of histaminergic ligands, including this compound, to the H2 receptor, suggesting the involvement of residues like Asp98, Asp186, Tyr250, Lys175, and Thr190 in the binding site. mdpi.com
Cytochrome P450 Enzyme System Inhibition by this compound
Beyond its effects on histamine receptors, this compound is also a well-known inhibitor of the hepatic cytochrome P450 (CYP) enzyme system. wikipedia.orgdrugbank.compatsnap.commedicaldialogues.indroracle.aimefst.hr This inhibition is a significant factor in its potential for drug interactions. wikipedia.orgpatsnap.comdroracle.ai
Isoenzyme Specificity and Inhibition Profiles (e.g., CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP2E1, CYP3A4)
This compound is recognized as a potent inhibitor of several CYP isoenzymes, including CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4. wikipedia.orgdrugbank.comnih.gov Research indicates that this compound appears to primarily inhibit CYP1A2, CYP2D6, and CYP3A4, being described as a moderate inhibitor of these isoforms. wikipedia.org These six isoenzymes (CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) are responsible for the metabolism of a large proportion of commonly used drugs. wikipedia.orgnih.govpharmajournal.net
Studies have investigated the inhibitory effects of this compound on specific CYP isoforms in human liver microsomes. For CYP1A2, this compound shows significantly greater inhibition compared to other H2-receptor antagonists like ranitidine and ebrotidine. nih.gov Similarly, this compound exhibits much stronger inhibition of CYP2D6 activity than ranitidine or ebrotidine. nih.gov For CYP3A4/5, ebrotidine appears to be a stronger inhibitor than this compound, which is in turn a much stronger inhibitor than ranitidine. nih.gov
An interactive data table summarizing the relative inhibitory effects of this compound on key CYP isoforms based on research findings could be presented as follows:
CYP Isoenzyme | Relative Inhibition by this compound (compared to Ranitidine/Ebrotidine) | Notes |
CYP1A2 | Much greater inhibition nih.gov | Primarily inhibited wikipedia.org |
CYP2C9 | Inhibited wikipedia.orgdrugbank.comnih.gov | |
CYP2C19 | Inhibited wikipedia.orgdrugbank.comnih.gov | |
CYP2D6 | Much greater inhibition nih.gov | Primarily inhibited wikipedia.org; Evidence of mechanism-based inhibition wikipedia.orgubc.caresearchgate.net |
CYP2E1 | Inhibited wikipedia.orgdrugbank.comnih.gov | |
CYP3A4/5 | Greater inhibition (compared to Ranitidine) nih.gov | Primarily inhibited wikipedia.org; Moderate inhibitor wikipedia.org |
Note: In an interactive table, clicking on a CYP isoenzyme could potentially link to more detailed data or research findings related to this compound's inhibition of that specific enzyme.
Competitive and Mechanism-Based (Suicide) Inhibition Mechanisms
This compound is reported to be a competitive and reversible inhibitor of several CYP enzymes. wikipedia.org Competitive inhibition occurs when the inhibitor molecule competes with the substrate molecule for binding to the enzyme's active site. mdpi.com this compound can reversibly inhibit CYP enzymes by binding directly to the complexed heme-iron in the active site, often via one of its imidazole ring nitrogen atoms, thereby blocking the oxidation of other substrates. wikipedia.org
In addition to reversible competitive inhibition, mechanism-based inhibition, also known as suicide inhibition, has been identified for this compound's inhibition of certain CYP isoforms, particularly CYP2D6. wikipedia.orgubc.caresearchgate.netmdpi.comdrugbank.comdvm360.com Mechanism-based inhibition involves the metabolic activation of the inhibitor by the enzyme itself to a reactive intermediate that then binds irreversibly or quasi-irreversibly to the enzyme, leading to long-lasting inactivation. mdpi.comdrugbank.comdvm360.com This process requires catalytic activity of the enzyme to generate the inhibitory species. mdpi.comdvm360.com Studies have suggested that this compound acts as a mechanism-based inactivator of CYP2D6. ubc.caresearchgate.net
Formation of Metabolite-Intermediate Complexes with Cytochrome P450
A key aspect of the mechanism-based inhibition by this compound involves the formation of a metabolite-intermediate (MI) complex with the cytochrome P450 enzyme. ubc.camdpi.comnih.govnih.gov This occurs when a metabolite of this compound, formed during the catalytic cycle of the CYP enzyme, binds tightly and stably to the heme iron of the enzyme. mdpi.comnih.govnih.gov This complex renders the enzyme inactive. mdpi.com
Evidence for the formation of a this compound metabolite-intermediate complex has been provided by studies, particularly in rats, where it was shown to selectively inhibit CYP2C11 by forming such a complex. nih.govnih.gov This complex formation can be generated in vitro by incubating microsomes with this compound in the presence of NADPH, a necessary cofactor for CYP activity. nih.gov The spectral properties observed in these studies are consistent with the presence of an MI complex. nih.gov While initially studied in animal models, the concept of metabolite-intermediate complex formation contributes to the understanding of this compound's inhibitory effects on human CYPs as well, particularly in the context of mechanism-based inhibition observed for enzymes like CYP2D6. ubc.ca The formation of these stable complexes leads to a time-dependent loss of enzyme activity that is not easily reversed, requiring the synthesis of new enzyme for activity recovery. dvm360.com
Pharmacological and Pharmacokinetic Investigations of Cimetidine
Research on Cimetidine Absorption and Distribution Dynamics
Research indicates that this compound is rapidly absorbed from the gastrointestinal tract following oral administration, with peak plasma concentrations typically observed within 1 to 2 hours ontosight.aiwikipedia.org. The absorption process can sometimes be discontinuous, leading to the observation of two peak plasma concentrations after oral dosing drugbank.com. Studies in healthy subjects report an absolute bioavailability of approximately 60%, although this can increase to around 70% in patients with peptic ulcer disease, with greater variability observed in this population drugbank.comnih.gov. The extent of absorption is generally not altered by food, but a delay in reaching peak plasma concentrations may occur drugbank.com. Partial gastrectomy has been shown to increase the systemic availability of this compound through mechanisms that are not yet fully understood drugbank.com.
Following absorption, this compound is distributed throughout the body, with a reported volume of distribution of approximately 0.8 to 1 L/kg in adults ontosight.aidrugbank.comumich.edu. Some studies suggest the volume of distribution at steady-state is about 80% of body weight nih.gov. This compound exhibits relatively low plasma protein binding, estimated to be between 13% and 25% in humans, which is generally considered to have no significant clinical or pharmacokinetic implications wikipedia.orgdrugbank.comdrugbank.com. Distribution studies indicate extensive uptake into tissues such as the kidney, lung, and muscle drugbank.com. This compound is also able to cross the blood-brain barrier, with a cerebrospinal fluid to plasma ratio of 0.1 to 0.2 drugbank.com.
Here is a summary of key absorption and distribution parameters:
Parameter | Value (Adults) | Notes | Source |
Absolute Bioavailability | ~60% (healthy) | Up to 70% in peptic ulcer patients | drugbank.comnih.gov |
Time to Peak Plasma Conc. | 1-2 hours | Can show double peaks after oral dose | ontosight.aiwikipedia.org |
Volume of Distribution | 0.8 - 1 L/kg | Approximately 80% of body weight at steady-state | ontosight.ainih.govumich.edu |
Plasma Protein Binding | 13% - 25% | Considered clinically insignificant | wikipedia.orgdrugbank.comdrugbank.com |
Metabolic Pathways and Metabolite Identification Studies of this compound
This compound undergoes relatively limited metabolism in the liver, with a significant portion of the administered dose excreted unchanged wikipedia.org. Hepatic metabolism involves the cytochrome P450 enzyme system, with specific isoenzymes such as CYP1A2, CYP2C19, and CYP3A4 implicated, although the precise contributions of each enzyme may not be fully clarified ontosight.aidrugbank.com. Flavin-containing monooxygenases are also suggested to play a role in this compound metabolism drugbank.com.
This compound Sulfoxide Formation and Other Metabolites
The primary metabolite of this compound is this compound sulfoxide, formed by the oxidation of the side-chain sulfur drugbank.comiarc.fr. This compound sulfoxide accounts for an estimated 10-15% of total elimination drugbank.com. Some sources indicate that this compound sulfoxide represents approximately 30% of the excreted material in humans wikipedia.org. Research has also identified a minor metabolite resulting from hydroxylation of a methyl group on the imidazole ring, contributing about 4% to total elimination drugbank.com. Other identified metabolites include this compound sulfone and 5-hydroxythis compound, and 5-hydroxythis compound sulfoxide ontosight.ai. Studies using small intestinal microsomes from different species have investigated the S-oxidation of this compound, suggesting contributions from both flavin-containing monooxygenases and cytochrome P450 enzymes in this process nih.gov.
Here is a summary of identified this compound metabolites:
Metabolite | Formation Pathway | Contribution to Elimination | Source |
This compound Sulfoxide | S-oxidation | 10-15% or ~30% | wikipedia.orgdrugbank.comiarc.fr |
Hydroxythis compound | Hydroxylation | ~4% (imidazole methyl group) | wikipedia.orgdrugbank.com |
This compound Sulfone | Further Oxidation | Mentioned as metabolite | ontosight.ai |
5-hydroxythis compound sulfoxide | Oxidation/Hydroxylation | Mentioned as metabolite | ontosight.ai |
Guanyl urea this compound | - | Mentioned as metabolite | wikipedia.org |
Elimination Kinetics and Renal Excretion Research
This compound is primarily eliminated from the body via the kidneys, with a significant proportion of the dose excreted unchanged in the urine wikipedia.orgdrugbank.comdrugbank.com. Following intravenous administration, the majority of the parent drug (58-77%) is eliminated unchanged renally drugbank.com. The elimination half-life of this compound is approximately 2 hours wikipedia.orgdrugbank.comnih.govdrugbank.com. Total systemic clearance is reported to be high, ranging from 500 to 600 ml/min, and is largely determined by renal clearance drugbank.com. Renal clearance values of around 293 ml/min have been observed in studies nih.gov.
Research in rats indicates that this compound clearance is greater than the glomerular filtration rate, suggesting active renal tubular secretion nih.gov. At low plasma concentrations, the ratio of this compound clearance to glomerular filtration rate was found to be 2.64, decreasing at higher concentrations nih.gov. This active secretion is mediated by the renal organic cation transport mechanism nih.gov. Passive reabsorption via nonionic diffusion may also occur to a modest extent when the urine is alkaline nih.gov. Studies in patients with renal failure demonstrate a reduced elimination rate and increased half-life of this compound, highlighting the importance of renal function in its clearance nih.govnih.gov.
Here is a summary of key elimination parameters:
Parameter | Value (Adults) | Notes | Source |
Primary Elimination Route | Renal Excretion | Primarily unchanged drug | wikipedia.orgdrugbank.comdrugbank.com |
Fraction Excreted Unchanged | 56% - 85% | After IV administration | wikipedia.orgdrugbank.com |
Elimination Half-life | Approximately 2 hours | Increases with age and renal impairment | wikipedia.orgdrugbank.comnih.govdrugbank.comnih.govnih.gov |
Total Systemic Clearance | 500 - 600 ml/min | Mainly renal clearance | drugbank.com |
Renal Clearance | ~293 ml/min | Varies with renal function and age | nih.govnih.gov |
Renal Secretion Inhibition of Co-administered Drugs
This compound is known to interact with numerous other medications, partly due to its ability to inhibit renal tubular secretion of organic cations nih.govcapes.gov.br. This occurs through competition for specific transport systems, particularly the organic cation transporters (OCTs) and multidrug and toxin extrusions (MATEs) in the renal tubules capes.gov.brnih.gov. Studies have shown that this compound can inhibit the renal clearance of various cationic drugs by interfering with these transporters nih.govresearchgate.netnih.govmdpi.com.
Research using in vitro models and in vivo studies has investigated the interaction of this compound with transporters like OCT2 and MATE1/2-K nih.govmdpi.comresearchgate.net. This compound has been identified as an inhibitor of OCT2 and MATEs, with some studies suggesting a greater potency for MATE1 nih.govmdpi.com. The inhibition of OCT2 by this compound may be substrate-dependent, meaning the extent of inhibition can vary depending on the co-administered drug researchgate.net. For example, studies have shown that this compound can significantly inhibit the renal secretion of drugs like metformin and glycopyrronium, which are substrates for these transporters researchgate.netnih.govbiorxiv.org. This inhibition can lead to increased plasma concentrations and altered pharmacokinetics of the co-administered drugs nih.govnih.govbiorxiv.org.
Studies have utilized this compound as a probe inhibitor to investigate the role of organic cation transporters in the disposition of other drugs researchgate.netnih.gov. Research involving co-administration of this compound with drugs like amiloride and glycopyrronium has demonstrated reductions in their renal clearance and increased systemic exposure nih.govnih.gov. For instance, this compound reduced the renal clearance of amiloride by a mean of 17% in healthy subjects nih.gov. Similarly, co-administration with this compound resulted in a 22% increase in the total systemic exposure (AUC) of glycopyrronium, correlated with a slight decrease in its renal clearance nih.gov. These findings underscore the importance of considering potential renal secretory interactions when this compound is co-administered with other renally cleared cationic compounds.
Cimetidine's Immunomodulatory and Anti-inflammatory Properties: Advanced Research
Modulation of Histamine-Mediated Immunosuppression via H2R Antagonism
Histamine, a key mediator in immune responses, can exert immunosuppressive effects by binding to histamine H2 receptors (H2R) present on various immune cells. researchgate.netnih.govmdpi.com Cimetidine, as an H2R antagonist, has been shown to reverse this histamine-mediated immunosuppression. researchgate.netnih.govmdpi.com By blocking histamine's binding to H2R, this compound can interfere with signals that suppress immune cell activity. researchgate.netnih.govmdpi.com This antagonism is considered a primary mechanism through which this compound exerts its immunomodulatory effects. researchgate.netnih.govmdpi.com Studies suggest that this reversal of immunosuppression may contribute to this compound's observed effects in various conditions, including certain cancers. researchgate.netnih.govmdpi.com
Effects on Innate Immune Cells
This compound influences the activity of several components of the innate immune system, which provides a rapid, non-specific defense against pathogens. researchgate.netnih.govuni.lu
Natural Killer (NK) Cell Activity Enhancement
Natural Killer (NK) cells are crucial for recognizing and eliminating abnormal cells, such as tumor cells and virus-infected cells. Research indicates that this compound can enhance NK cell activity. researchgate.netnih.govmdpi.com Studies have shown that this compound augmented natural killer cell activity in both healthy individuals and patients with certain cancers, such as melanoma and colorectal carcinoma. nih.gov This enhancement was observed in vitro and, in some cases, in vivo. nih.gov One study noted that this compound tended to enhance NK cell activity in splenic lymphocytes of rats. spandidos-publications.com Another study on patients with chronic lymphocytic leukemia (B-CLL) showed that this compound treatment increased peripheral blood NK activity. nih.gov
Here is a table summarizing some findings on this compound's effect on NK cells:
Study Population | This compound Effect on NK Activity | Notes | Source |
Healthy controls & cancer patients | Augmented | In vitro effect observed in majority of subjects. | nih.gov |
Rats (splenic lymphocytes) | Tended to enhance | Proportion of NK cells not affected, but activity showed enhancement. | spandidos-publications.com |
Patients with B-CLL | Increased | Peripheral blood NK activity rose after treatment. | nih.gov |
Dendritic Cell (DC) Antigen-Presenting Activity
Dendritic cells (DCs) are critical antigen-presenting cells that bridge the innate and adaptive immune responses by processing antigens and presenting them to T lymphocytes. virtualtrials.orgresearchgate.net this compound has been shown to influence DC function, specifically enhancing their antigen-presenting capacity. researchgate.netnih.govmdpi.comvirtualtrials.org Studies have demonstrated that this compound can stimulate the maturity of immature DCs and enhance their ability to prime T cells. researchgate.net In patients with colorectal cancer, this compound modulated the antigen-presenting capacity of dendritic cells. virtualtrials.orgnih.gov This effect may contribute to an enhanced anti-tumor cell-mediated immune response. nih.gov While some research suggests this effect might be mediated by a mechanism not directly related to H2 receptors, other studies highlight the role of H2R antagonism in reversing histamine's inhibitory effects on DC function. nih.govresearchgate.net
Neutrophil, Monocyte, and Macrophage Function Modulation
Neutrophils, monocytes, and macrophages are key phagocytic cells involved in innate immunity and inflammation. researchgate.netnih.govuni.lu this compound has been reported to have stimulatory effects on the effector functions of these cells. researchgate.netnih.govuni.lu Histamine, through H2R, can modulate the function of these cells. researchgate.netnih.govuni.lu this compound, by blocking H2R, can reverse some of these effects. researchgate.netnih.govuni.lu For instance, histamine can inhibit human neutrophil chemotaxis via H2R, an effect that this compound may counteract. uni.lu this compound has also been shown to induce the production of interleukin (IL)-18, an antitumor cytokine, by human monocytes and dendritic cells. This effect was observed with this compound but not with other H2R antagonists like ranitidine and famotidine, suggesting a potential H2-agonist activity of this compound in this context. In some studies, this compound has been shown to influence macrophage polarization, potentially favoring anti-tumor M1 macrophages. mdpi.comnih.gov
Effects on Adaptive Immune Cells
This compound also impacts the adaptive immune system, which is characterized by its specificity and memory. researchgate.netnih.govuni.lu
T-Lymphocyte Subpopulation Modulation (CD3+, CD4+, CD8+ T Cells)
T lymphocytes, including CD3+, CD4+ (helper T cells), and CD8+ (cytotoxic T cells), play central roles in cell-mediated immunity. researchgate.netnih.govuni.luwaocp.org Research indicates that this compound can modulate these T cell subpopulations. researchgate.netnih.govuni.lumdpi.comresearchgate.net Histamine can suppress CD8+ cytotoxic T cells via H2R, and this compound has been shown to reverse this suppression, potentially enhancing antitumor activity. researchgate.net this compound has been reported to increase the total number of CD3+, CD4+, and CD8+ T cells in some contexts. researchgate.netnih.govmdpi.com For example, a study in a colon cancer model showed that this compound increased the CD3+, CD4+, and CD8+ T cell populations in the tumor microenvironment. mdpi.com However, another study in HIV-infected patients found no significant differences in CD4+ cell counts between this compound and placebo groups. jwatch.orgoup.com
This compound's effects on T cell subsets can vary depending on the context. It has been suggested to activate Th1 cells, which are involved in cell-mediated immunity, and potentially lower Th2 cell activity, which is associated with humoral immunity and allergic responses. clinicaltrials.eu this compound may also reduce the activity of regulatory T cells (Tregs), which suppress immune responses. researchgate.netresearchgate.net
Here is a table summarizing some findings on this compound's effect on T cell subpopulations:
T Cell Subpopulation | This compound Effect | Notes | Source |
CD3+ T cells | Increased populations | Observed in tumor microenvironment in a colon cancer model and in patients with GI cancers. | researchgate.netnih.govmdpi.com |
CD4+ T cells | Increased populations | Observed in tumor microenvironment in a colon cancer model and in patients with GI cancers. | researchgate.netnih.govmdpi.com |
CD8+ T cells | Increased populations | Observed in tumor microenvironment in a colon cancer model and in patients with GI cancers. | researchgate.netnih.govmdpi.com |
CD4+ T cells | No significant difference | Observed in HIV-infected patients compared to placebo in one study. | jwatch.orgoup.com |
Th1 cells | Activation | Suggested in the context of atopic dermatitis and viral warts. | researchgate.netclinicaltrials.eu |
Th2 cells | Lowering activity | Suggested in the context of atopic dermatitis. | clinicaltrials.eu |
Regulatory T cells | Reduced immunosuppression | This compound reduces the regulatory/suppressor T cell-mediated immunosuppression. | researchgate.netuni.luresearchgate.net |
Regulatory T Cell (Treg) Function Inhibition
Research indicates that this compound can exert inhibitory effects on the function of regulatory T cells (Tregs). Tregs play a crucial role in maintaining immune tolerance and suppressing immune responses. Studies have shown that this compound can impair Treg cell activity. waocp.orgtandfonline.comresearchgate.net This inhibition of Treg function by this compound may contribute to enhanced immune responses. tandfonline.comresearchgate.net For instance, this compound has been reported to enhance immune responses to hepatitis B DNA vaccination, potentially via the inhibition of Treg cells. tandfonline.comresearchgate.net Furthermore, this compound has been shown to lead to the degradation of FOXP3, a key transcription factor associated with Treg cells, which is accompanied by impaired Treg cell activity. waocp.orgresearchgate.net
Th1, Th2, and Th17 Cytokine Profile Alterations
This compound has been observed to modulate the balance of T helper (Th) cell subsets, specifically altering the Th1, Th2, and Th17 cytokine profiles. Th1 cells are generally associated with cell-mediated immunity, Th2 cells with humoral immunity and allergic responses, and Th17 cells with inflammation and defense against extracellular pathogens. tandfonline.comtandfonline.com
Studies have suggested that this compound can influence both Th1- and Th2-type immune responses. tandfonline.com Some research indicates that this compound can enhance Th1-type cytokines while reducing Th2-associated cytokines. researchgate.net For example, in the context of Lyme disease, where suppression of Th1 responses may occur, this compound therapy has been shown to promote levels of Th1-associated cytokines such as IL-12, TNF-α, and IFN-γ, while reducing levels of the Th2-associated cytokine IL-10, potentially helping to restore immune balance. researchgate.net
Furthermore, this compound has been reported to potentiate Th1/Th2 dual polarization. tandfonline.com In addition to its effects on Th1 and Th2 responses, this compound has also been shown to influence Th17 cells. Studies have indicated that this compound can lead to the upregulation of Th1 and Th17 cells while downregulating Th2 and Treg cells. researchgate.netresearchgate.net
Tumor-Infiltrating Lymphocyte (TIL) Response Augmentation
This compound has demonstrated the ability to augment the response of tumor-infiltrating lymphocytes (TILs). TILs are immune cells that migrate into tumors and are crucial for the anti-tumor immune response. Enhancing TIL activity is a key strategy in cancer immunotherapy.
Research suggests that this compound can enhance the tumor-infiltrating lymphocyte response. mdpi.com Perioperative administration of this compound has been shown to improve systematic immune response and tumor-infiltrating lymphocytes in patients with colorectal cancer. waocp.orgcancerchoices.org Clinical studies have revealed higher rates of tumor-infiltrating lymphocyte responses after surgery among patients with gastrointestinal cancer treated with this compound compared to control groups. cancerchoices.org Similarly, enhanced lymphocyte responses have been observed after elective resection in patients with colorectal carcinoma treated with this compound. cancerchoices.orgnih.gov this compound has also been shown to increase the number of TILs in colorectal and gastric cancer patients. nih.gov
This compound's Influence on Cytokine and Chemokine Expression
Interleukin (IL) Regulation (e.g., IL-2, IL-10, IL-12, IL-17)
This compound has been shown to regulate the expression of several interleukins. Studies in animal models have demonstrated that this compound can significantly augment the levels of IL-2, IL-10, IL-12, and IL-17, particularly in contexts of immunosuppression such as after burn injury. tandfonline.comresearchgate.nettandfonline.comnih.gov
Specifically:
IL-2: this compound has been shown to significantly augment IL-2 levels. tandfonline.comresearchgate.nettandfonline.comnih.gov IL-2 is a key cytokine involved in T cell proliferation and differentiation. tandfonline.comtandfonline.comwikipedia.org
IL-10: this compound treatment has been observed to enhance IL-10 levels in certain conditions. tandfonline.comresearchgate.nettandfonline.comnih.gov IL-10 is generally considered an anti-inflammatory cytokine that can suppress immune responses. tandfonline.comtandfonline.comnih.gov
IL-12: this compound can significantly increase IL-12 levels. tandfonline.comresearchgate.nettandfonline.comnih.gov IL-12 is a crucial cytokine for promoting Th1 cell differentiation and cell-mediated immunity. waocp.orgtandfonline.comtandfonline.com
IL-17: Augmentation of IL-17 levels by this compound has also been reported. tandfonline.comresearchgate.nettandfonline.comnih.gov IL-17 is a cytokine produced by Th17 cells and is involved in inflammatory responses and host defense. tandfonline.comtandfonline.com
In addition to these, this compound has been reported to increase the levels of other cytokines such as IFN-γ, TNF-α, and IL-15. mdpi.comwaocp.orgresearchgate.netnih.gov Conversely, this compound can inhibit histamine-induced IL-10 expression while promoting histamine-reduced IL-12 secretion in dendritic cells. waocp.org
Transforming Growth Factor-Beta (TGF-β) Modulation
This compound has been shown to modulate the levels of Transforming Growth Factor-Beta (TGF-β). tandfonline.comresearchgate.nettandfonline.com TGF-β is a pleiotropic cytokine with various functions, including immune regulation and tissue fibrosis. tandfonline.comtandfonline.comnih.govnih.govresearchgate.net It is also considered a Treg cytokine. tandfonline.comresearchgate.net
Research indicates that this compound can significantly diminish elevated TGF-β levels in certain pathological contexts, such as after burn injury. tandfonline.comresearchgate.nettandfonline.comnih.gov This reduction in TGF-β by this compound may contribute to its immune-enhancing effects, as TGF-β can suppress immune responses. tandfonline.comresearchgate.nettandfonline.com
Immunological Mechanisms in Specific Pathological Contexts
The immunomodulatory effects of this compound have been investigated in the context of various pathological conditions, including cancer and burn injury.
In cancer, this compound's immunomodulatory properties are considered a possible mechanism for its observed anti-cancer effects. mdpi.com By interfering with histamine-mediated immunosuppression, this compound may regulate immune cell activities that are crucial for controlling tumor growth. mdpi.com This includes enhancing the tumor-infiltrating lymphocyte response and increasing populations of CD3+, CD4+, and CD8+ T cells within the tumor microenvironment. mdpi.com this compound's ability to modulate cytokine profiles, such as increasing pro-inflammatory cytokines and decreasing anti-inflammatory ones, may also contribute to an anti-tumor immune response. researchgate.net
In the context of burn injury, which is often associated with immunosuppression, this compound has been shown to enhance immune responses. tandfonline.comresearchgate.nettandfonline.com This includes augmenting delayed-type hypersensitivity responses and restoring suppressed levels of various cytokines like IL-2, IL-10, IL-12, and IL-17. tandfonline.comresearchgate.nettandfonline.comnih.gov this compound's ability to diminish elevated TGF-β levels post-burn injury may also play a role in mitigating burn-induced immunosuppression. tandfonline.comresearchgate.nettandfonline.comnih.gov
Furthermore, this compound has been explored for its immunomodulatory effects in other conditions, such as atopic dermatitis, where it may help by activating Th1 cells, lowering Th2 activity, and reducing IgE levels. clinicaltrials.eu Its potential to induce dendritic cell activation and promote pro-inflammatory T cell responses while weakening immunosuppressive T cell responses has also been noted. researchgate.netresearchgate.net
Here is a table summarizing some of the observed cytokine modulation effects of this compound:
Cytokine | Observed Effect of this compound Treatment | Context(s) | Source(s) |
IL-2 | Augmented levels | Burn injury, HBV DNA vaccination | tandfonline.comresearchgate.nettandfonline.comnih.gov |
IL-10 | Augmented levels (in some contexts), inhibited histamine-induced expression | Burn injury, HBV DNA vaccination, DCs | waocp.orgtandfonline.comresearchgate.nettandfonline.comnih.gov |
IL-12 | Augmented levels, promoted histamine-reduced secretion | Burn injury, HBV DNA vaccination, DCs, Cancer | waocp.orgtandfonline.comresearchgate.nettandfonline.comnih.gov |
IL-17 | Augmented levels | Burn injury | tandfonline.comresearchgate.nettandfonline.comnih.gov |
TGF-β | Diminished elevated levels | Burn injury | tandfonline.comresearchgate.nettandfonline.comnih.gov |
IFN-γ | Increased quantities | HBV DNA vaccination, Cancer | waocp.orgresearchgate.netresearchgate.net |
TNF-α | Restoration of decreased levels, increased levels | Experimental tumor, Cancer | mdpi.comwaocp.orgresearchgate.netnih.gov |
IL-15 | Restoration of decreased levels, increased levels | Experimental tumor, Cancer | mdpi.comwaocp.orgresearchgate.netnih.gov |
Immune Modulation in Post-Burn Injury Contexts
Research indicates that this compound can significantly augment immune responses that are typically suppressed following thermal trauma. Studies in animal models have demonstrated that this compound restores burn-induced suppression of delayed-type hypersensitivity (DTH) responses. tandfonline.comtandfonline.comresearchgate.net DTH response, a measure of cell-mediated immunity, is markedly suppressed for up to 30 days after burn trauma, with maximal suppression occurring between 10 to 14 days post-injury. researchgate.netresearchgate.net Administration of this compound has been shown to significantly enhance DTH responses at various time points post-burn. tandfonline.comtandfonline.comresearchgate.net
Beyond DTH responses, this compound has been observed to influence cytokine levels in the post-burn period. Studies have shown that this compound can significantly augment the levels of several interleukins, including IL-2, IL-10, IL-12, and IL-17, which are normally suppressed after thermal trauma. tandfonline.comtandfonline.comresearchgate.net For instance, significant increases in IL-2, IL-10, IL-12, and IL-17 levels were observed at specific post-burn day (PBD) time points in this compound-treated burned subjects compared to untreated burned counterparts. tandfonline.comtandfonline.comresearchgate.net Conversely, this compound significantly diminished burn-induced elevated levels of TGFβ, a regulatory T (Treg) cell cytokine, at later time points. tandfonline.comtandfonline.com This effect is consistent with the understanding that this compound enhances immune responses, in part, by down-regulating Treg cell function. tandfonline.comtandfonline.com
Furthermore, this compound has been shown to improve T-cell proliferation and enhance the percentage of CD8+ T cells in burn-injured patients. researchgate.net While the percentage of CD3+ and CD4+ T cells and B cells (CD19+ HLA-DR+ cells) did not change significantly in this compound-treated patients compared to untreated individuals, the restoration of peripheral blood mononuclear cell (PBMC) proliferation rate was observed following this compound treatment. nih.gov
The beneficial impacts of this compound on immune parameters have also been noted in the context of spleen architecture in animals with burn injuries. waocp.org
Here is a summary of the effects of this compound on immune parameters in post-burn injury contexts based on research findings:
Immune Parameter | Effect of Burn Injury (Untreated) | Effect of this compound Treatment (Burned Subjects) | Key Findings | Source(s) |
Delayed-Type Hypersensitivity (DTH) | Suppressed | Augmented | Restores suppression; significant enhancement at various post-burn time points. | tandfonline.comtandfonline.comresearchgate.netnih.gov |
IL-2 Levels | Suppressed | Augmented | Significant increase at PBD 3, 5, and 10. | tandfonline.comtandfonline.comresearchgate.net |
IL-10 Levels | Suppressed | Augmented | Significant increase at PBD 1 and 5. | tandfonline.comtandfonline.comresearchgate.net |
IL-12 Levels | Suppressed | Augmented | Significant increase at PBD 3, 5, 10, and 14. | tandfonline.comtandfonline.comresearchgate.net |
IL-17 Levels | Suppressed | Augmented | Significant increase at PBD 3 and 14. | tandfonline.comtandfonline.comresearchgate.net |
TGFβ Levels | Biphasic (decreased then increased) | Diminished elevated levels | Significant decrease of elevated levels at PBD 14; associated with down-regulation of Treg function. | tandfonline.comtandfonline.com |
T-cell Proliferation | Suppressed | Improved/Restored | Restoration of PBMC proliferation rate observed. | researchgate.netnih.gov |
CD8+ T cell Percentage | Not specified/Reduced | Enhanced | Increased frequency of CD8+ T cells in peripheral blood. | researchgate.netnih.gov |
CD4+ T cell Percentage | Reduced | No significant change | Percentage of CD4+ T cells did not significantly change with treatment in one study. | researchgate.netnih.gov |
CD3+ T cell Percentage | Reduced | No significant change | Percentage of CD3+ T cells did not significantly change with treatment in one study. | researchgate.netnih.gov |
CD19+ HLA-DR+ Cells (B cells) | Increased | No significant change | Percentage of B cells did not significantly change with treatment in one study. | researchgate.netnih.gov |
Spleen Index | Augmented | Reduced | Beneficial impacts on spleen architecture noted in animal models. | waocp.org |
Effects on Hypersensitivity Responses
This compound's influence on hypersensitivity responses has also been explored in research. Studies have linked the use of this compound to an increase in Th1-type cytokine-mediated immune responses and delayed-type hypersensitivity reactions. springermedizin.de In a study involving mice sensitized with ovalbumin, administration of this compound resulted in a significant increase in both specific-IgE and IL-5 levels in the culture supernatants of spleen cells. springermedizin.de However, levels of Th1-, Th2-, and Th17-type cytokines did not differ between treated and untreated mice in this specific study. springermedizin.de
Further research in humans has demonstrated that this compound can exhibit pro-inflammatory effects, including increased release of Th1-type cytokines, particularly IL-12 and IL-2. springermedizin.de
This compound has been shown to reduce the suppressor activity of Foxp3+ CD4+ CD25+ Treg cells, potentially through increased degradation of Foxp3. springermedizin.de This reduction in Treg cell activity could contribute to enhanced immune responses, including those involved in delayed hypersensitivity. springermedizin.de
In a study on allergic contact hypersensitivity (ACH) in mice, treatment with this compound during the induction phase significantly enhanced the ear swelling response throughout the first 48 hours after challenge. nih.gov Histological examination revealed a more intense cellular infiltrate in this compound-treated animals. nih.gov This enhancement of ACH by this compound is thought to be independent of effects on mast cells or antigen-presenting cells, but may be related to an inhibition of the induction of T-suppressor cells at the time of sensitization. nih.gov
While some research suggests a link between this compound and enhanced hypersensitivity responses, it's important to note that the role of H2-antagonists in the treatment of conditions like urticaria is considered weak and unreliable by some reviews. springermedizin.de However, the addition of an H2-antagonist to H1-antagonist therapy has shown promise in specific types of urticaria, such as cholinergic urticaria, which involves complex pathogenesis beyond solely IgE-mediated mechanisms. springermedizin.de
Here is a summary of the effects of this compound on hypersensitivity responses based on research findings:
Hypersensitivity Parameter | Effect of this compound Treatment | Key Findings | Source(s) |
Delayed-Type Hypersensitivity (DTH) | Increased | Linked to increased Th1-type cytokine responses; significant enhancement of allergic contact hypersensitivity in mice. | springermedizin.denih.gov |
Specific-IgE Levels | Increased (in ovalbumin-sensitized mice) | Significant increase observed in culture supernatants of spleen cells. | springermedizin.de |
IL-5 Levels | Increased (in ovalbumin-sensitized mice) | Significant increase observed in culture supernatants of spleen cells. | springermedizin.de |
Th1-type Cytokines (IL-12, IL-2) | Increased release (in humans) | Demonstrated pro-inflammatory effects. | springermedizin.de |
Treg Cell Suppressor Activity | Reduced | May contribute to enhanced immune responses, potentially through Foxp3 degradation. | springermedizin.de |
Allergic Contact Hypersensitivity | Enhanced (during induction phase in mice) | Significant increase in ear swelling response and more intense cellular infiltrate; potentially related to inhibition of T-suppressor cells. | nih.gov |
Investigational Therapeutic Applications of Cimetidine Beyond Gastric Acid Secretion Inhibition
Oncological Research and Antineoplastic Effects
Research indicates that cimetidine may exert antineoplastic effects through several mechanisms, including the inhibition of cancer cell proliferation, modulation of the immune system, interference with cell adhesion, and anti-angiogenic properties. nih.govnih.gov Studies have explored these effects across various cancer types, with a notable focus on gastrointestinal malignancies, melanoma, and renal cell carcinoma. chemicalbook.comnih.govmdpi.comoncology-central.com
Colorectal Carcinoma: Adjuvant Therapy and Survival Benefit Studies
Numerous studies have investigated this compound as an adjuvant therapy in colorectal carcinoma patients following surgical resection. nih.govloveyourbuns.orgijsra.net The rationale behind this research stems from early observations suggesting a potential survival benefit associated with this compound use in cancer patients. nih.govloveyourbuns.org
Another study involving 64 colorectal cancer patients who underwent curative operations examined the effects of this compound treatment on survival and recurrence. researchgate.net Patients in the this compound group received this compound along with 5-fluorouracil, while the control group received 5-fluorouracil alone. researchgate.net The 10-year survival rate in the this compound group was significantly higher compared to the control group. researchgate.net
Table 1: 10-Year Survival Rates in a Colorectal Cancer Study (this compound + 5-FU vs. 5-FU alone) researchgate.net
Treatment Group | 10-Year Survival Rate | P-value |
This compound + 5-FU | 84.6% | 0.0001 |
5-FU alone | 49.8% |
Note: Data derived from a study of 64 colorectal cancer patients who received curative operation. researchgate.net
Perioperative this compound Administration Research
The timing of this compound administration relative to surgery has been a focus of research, particularly in the perioperative period. ecancer.orgnih.govnih.gov Surgical resection, a common cancer treatment, can lead to post-surgical immune suppression, potentially increasing the risk of recurrence or metastatic spread. ecancer.org Perioperative this compound administration has been investigated for its potential to mitigate this immunosuppression and reduce the risk of disease recurrence in colorectal cancer patients undergoing curative resection. ecancer.orgnih.govresearchgate.net
An Australian and New Zealand Phase II trial is currently investigating the perioperative use of this compound in patients with colorectal cancer treated with curative resection. ecancer.org The primary outcome of this study is 2-year disease-free survival, with subgroup analysis focusing on patients with positive tumor staining for sialyl Lewis antigens. ecancer.org
A retrospective study involving stage III colorectal cancer patients who underwent surgical resection and received chemotherapy investigated the effect of perioperative this compound. ijsra.netnih.gov Ten out of 38 patients received perioperative this compound in addition to chemotherapy. ijsra.netnih.gov The results indicated that time to recurrence and cancer deaths were prolonged in the chemotherapy plus this compound group compared to the group receiving chemotherapy alone. nih.gov
Table 2: Time to Recurrence in Stage III Colorectal Cancer Patients (Chemotherapy + this compound vs. Chemotherapy alone) nih.gov
Treatment Group | Mean Time to Recurrence (Days) ± SD | P-value |
Chemotherapy + this compound | 1078 ± 290 | 0.03 |
Chemotherapy alone | 446 ± 62 |
Note: Data derived from a retrospective study of 38 stage III colorectal cancer patients. nih.gov
Inhibition of Cancer Cell Adhesion and Metastasis (e.g., E-selectin)
One proposed mechanism for this compound's antineoplastic effect is its ability to inhibit cancer cell adhesion to endothelial cells, thereby potentially preventing metastasis. ecancer.orgaacrjournals.orgchemicalbook.com This effect is believed to be mediated, in part, by the interaction between tumor sialyl Lewis antigens and E-selectin expressed on the endothelium. ecancer.orgaacrjournals.orgchemicalbook.com
Studies have demonstrated that this compound can block the adhesion of colorectal tumor cell lines to endothelial cell monolayers in vitro and suppress the metastasis of tumor cells in nude mouse models. aacrjournals.org This anti-adhesive effect appears to involve the down-regulation of E-selectin expression on endothelial cells. aacrjournals.orgniph.go.jp Notably, this effect seems to be independent of this compound's histamine H2 receptor antagonist activity, as other H2 receptor antagonists like famotidine and ranitidine have not shown similar effects on cell adhesion or patient survival. aacrjournals.org this compound has been shown to inhibit the increase in E-selectin expression at the protein level without affecting mRNA expression. chemicalbook.com
Correlation with Sialyl Lewis-X/A Expression
Research suggests a correlation between the effectiveness of this compound treatment in colorectal cancer patients and the expression levels of sialyl Lewis-X (sLeX) and sialyl Lewis-A (sLeA) antigens on tumor cells. ecancer.orgchemicalbook.comnih.govnih.gov These antigens are ligands for E-selectin and their expression on tumor cells is associated with poor prognosis and metastasis. chemicalbook.comnih.govnih.govnih.gov
Studies have shown that this compound treatment significantly improved survival in colorectal cancer patients whose tumors expressed high levels of sLeX and sLeA. nih.govnih.gov Conversely, in patients with no or low levels of sLeX and sLeA expression, this compound did not show a significant beneficial effect on survival. nih.govnih.gov
Table 3: 10-Year Cumulative Survival Rates in Colorectal Cancer Patients Stratified by Sialyl Lewis-X Expression nih.govnih.gov
Sialyl Lewis-X Expression | Treatment Group | 10-Year Cumulative Survival Rate | P-value |
High | This compound | 95.5% | 0.0001 |
High | Control | 35.1% | |
Low/None | This compound | 70.0% | n.s. |
Low/None | Control | 85.7% |
Note: Data derived from a study of colorectal cancer patients. nih.govnih.gov
Similarly, studies stratifying patients based on sLeA expression have shown a beneficial effect of this compound in patients with high sLeA levels. nih.gov
Table 4: 10-Year Cumulative Survival Rates in Colorectal Cancer Patients Stratified by Sialyl Lewis-A Expression nih.gov
Sialyl Lewis-A Expression | Treatment Group | 10-Year Cumulative Survival Rate | P-value |
High | This compound | 90.9% | 0.0001 |
High | Control | 20.1% | |
Low/None | This compound | 80.0% | n.s. |
Low/None | Control | 90.9% |
Note: Data derived from a study of colorectal cancer patients. nih.gov
These findings suggest that the expression of sialyl Lewis antigens on tumor cells may serve as a predictive marker for the efficacy of this compound as an adjuvant therapy in colorectal cancer. nih.govnih.gov
Gastric Cancer Research
This compound has also been investigated in the context of gastric cancer. Early studies explored the potential effect of this compound on survival after gastric cancer treatment. ecancer.org While some initial reports suggested a potential benefit, larger, more recent studies have yielded varied and sometimes inconclusive results regarding this compound's impact on survival in gastric cancer patients. nih.gov However, the inhibitory effect of this compound on cell adhesion has also been demonstrated for gastric cancer cells. ecancer.orgresearchgate.net
Melanoma and Renal Cell Carcinoma Investigations
Investigations into this compound's effects have extended to melanoma and renal cell carcinoma. aacrjournals.orgnih.govmdpi.comoncology-central.comresearchgate.net Early clinical evidence suggested that this compound might have some effect on renal cell carcinoma. ecancer.orgcancerchoices.org A small trial combining this compound with coumarin in patients with metastatic renal cell carcinoma reported an objective response rate of 33.3%. ecancer.orgcancerchoices.org Another study investigating this compound in combination with human lymphoblastoid interferon-alpha in patients with advanced renal cell carcinoma reported an objective response rate of 41%. ecancer.orgcancerchoices.org
In melanoma, investigation of this compound as a monotherapy in metastatic melanoma was explored in small Phase II trials. nih.gov One trial involving previously untreated patients with metastatic melanoma treated with oral this compound observed objective responses in a subset of patients, including one long-lasting complete response. nih.gov However, later studies investigating this compound in combination with immunotherapy approaches in metastatic melanoma did not demonstrate significant differences compared to non-cimetidine arms. nih.govascopubs.org Despite mixed results, this compound's potential role in melanoma, possibly through immunomodulatory effects by blocking histamine activation of suppressor T-cells, continues to be explored. iastate.edu
Breast Cancer Models and T-Cell Response Modulation
Research in breast cancer models has investigated this compound's ability to modulate T-cell responses. Studies using a breast cancer model in Balb/c mice, established with the 4T1 cell line, explored the effects of this compound and ibuprofen, alone and in combination, on T cell-related parameters. waocp.orgnih.govnih.gov Untreated cancerous mice showed a lower percentage of splenic Th1 cells and plasma IFN-γ levels, along with a higher percentage of splenic Treg cells and plasma TGF-β levels compared to healthy mice. waocp.orgnih.govnih.gov Treatment with this compound, ibuprofen, or their combination increased the frequency of Th1 cells and IFN-γ levels while reducing the frequencies of Treg cells and TGF-β levels in BC-bearing mice. waocp.orgnih.govnih.gov Specifically, this compound treatment resulted in a significant reduction in the percentage of splenic Treg cells compared to untreated cancerous mice (P<0.02). waocp.orgnih.gov The combination of this compound and ibuprofen also significantly increased T-bet expression compared to untreated mice (P<0.006). waocp.orgnih.govnih.gov this compound and/or ibuprofen treatment also reduced intra-tumoral expression of FOXP3 and RORγt. waocp.orgnih.govnih.gov These findings suggest that this compound can influence the balance of T-cell subsets in the context of breast cancer models, potentially enhancing anti-tumor immunity.
Table 1: Effects of this compound and Ibuprofen on T-Cell Parameters in a Mouse Breast Cancer Model
Treatment Group | Splenic Th1 Cells (%) | Plasma IFN-γ Levels | Splenic Treg Cells (%) | Plasma TGF-β Levels | Intra-tumoral FOXP3 Expression | Intra-tumoral RORγt Expression | Intra-tumoral T-bet Expression |
Untreated Cancerous Mice | Lower | Lower | Higher | Higher | Higher | Higher | Lower |
This compound Treated Mice | Increased (P<0.05) | Increased (P<0.004) | Reduced (P<0.02) | Reduced (P<0.006) | Reduced (P<0.006) | Reduced (P<0.04) | Increased |
Ibuprofen Treated Mice | Increased (P<0.007) | Increased (P<0.0001) | Reduced (P<0.03) | Reduced (P<0.02) | Reduced (P<0.005) | Reduced (P<0.03) | Increased |
This compound + Ibuprofen | Increased (P<0.005) | Increased (P<0.03) | Reduced (P<0.01) | Reduced (P<0.002) | Reduced (P<0.005) | Reduced (P<0.05) | Increased (P<0.006) |
Note: P-values indicate statistical significance compared to untreated cancerous mice. "Increased" or "Reduced" without P-values indicate observed trends.
Combination Therapies in Oncology Research
This compound has been investigated in combination with other therapies in oncology research, particularly in colorectal cancer and malignant melanoma. Some clinical studies have indicated that this compound may offer a survival benefit in patients with colorectal cancer after surgical resection. nih.govpharmacytimes.com Preclinical evidence suggests this benefit might extend to other cancer types. pharmacytimes.com The potential anti-cancer effects of this compound are thought to involve various mechanisms, including immunomodulation, inhibition of cancer cell proliferation, effects on histamine metabolism, blocking E-selectin expression to inhibit cancer cell adhesion and prevent metastasis, and inhibiting angiogenesis. nih.gov
In malignant melanoma, a provocative report suggested a potential role for this compound, an inhibitor of suppressor T cell function, in managing disseminated malignant melanoma. ascopubs.org A phase II study evaluating single-agent this compound in patients with advanced malignant melanoma reported one complete response and two partial regressions among 19 patients. ascopubs.org Another study involving patients who received interferon-alpha and oral this compound reported objective regressions, although the respective contributions of each drug were not determined. ascopubs.org
Dermatological Research Applications
This compound has been explored for its potential therapeutic effects in various dermatological conditions, often leveraging its immunomodulatory properties. escholarship.orgnih.gov
Molluscum Contagiosum and Viral Warts
This compound has been investigated as a treatment for molluscum contagiosum and viral warts, particularly in children. escholarship.orgnih.govmatheny.infoaafp.orgkoreamed.org Some open trials and case reports suggested a benefit of oral this compound for molluscum contagiosum and viral warts. matheny.infoaafp.orgjwatch.org For molluscum contagiosum, one study in children reported clearance of lesions in a significant proportion of patients treated with oral this compound. jwatch.org However, other studies, including double-blind, placebo-controlled trials, have not found this compound to be significantly more effective than placebo for clearing molluscum contagiosum. escholarship.orgmatheny.infodrugbank.comdroracle.ai
Similarly, for viral warts, while some studies indicated potential effectiveness, particularly in children, double-blind, placebo-controlled studies have yielded conflicting results, with some showing no statistically significant superiority over placebo. escholarship.orgmatheny.infoaafp.org A trend toward efficacy in younger patients has been suggested. matheny.infoaafp.org One promising area of research is the use of this compound in conjunction with other therapies for warts. escholarship.orgaafp.org A combination regimen of this compound and levamisole was reported to be superior to this compound alone in treating warts in adults and children. escholarship.orgaafp.org
Urticaria and Mastocytosis
This compound appears to have a role in the treatment of chronic idiopathic urticaria and some other types of urticaria when used in combination with various H1 blockers. escholarship.orgdrugbank.com The combination of an antihistamine and an H2 antagonist, such as chlorpheniramine and this compound, appears to be effective for symptomatic dermatographism. escholarship.orgdrugbank.com Studies have shown that the combination of H1 and H2 receptor antagonists can improve clinical outcomes in patients with acute urticaria symptoms compared to using either antagonist alone. mdpi.com For chronic idiopathic urticaria, the addition of this compound has been effective in some patients who did not completely respond to adequate doses of H1 blockers. mdpi.comresearchgate.net
In systemic mastocytosis, this compound has been used to manage symptoms. nih.govdrugbank.com A case report described a patient with systemic mastocytosis and gastric hypersecretion treated with this compound, which resulted in the healing of a duodenal ulcer and marked amelioration of cutaneous symptoms. nih.gov This suggests that some cutaneous symptoms of mastocytosis may be mediated via histamine H2 receptors in the skin. nih.gov
Atopic Dermatitis: Immune System Modulation
Research has explored this compound as an adjuvant therapy for atopic dermatitis, particularly acute-extrinsic atopic dermatitis, due to its potential immunomodulatory effects. researchgate.netclinicaltrials.eunih.gov this compound is believed to modulate the immune system by activating Th1 responses and lowering Th2 activity, as well as potentially reducing IgE levels, which may help decrease the severity of atopic dermatitis symptoms. researchgate.netclinicaltrials.eu
A double-blind randomized controlled trial involving patients with acute extrinsic atopic dermatitis assessed the effectiveness of this compound as an adjuvant to standard treatment. researchgate.netnih.gov Significant differences were observed in SCORing Atopic Dermatitis (SCORAD) and objective SCORAD changes in the group receiving this compound compared to the control group at various time points. researchgate.netnih.gov Significant changes in IgE levels were also noted in the this compound group. researchgate.netnih.gov However, there were no significant changes in IFN-γ, IL-12, and IL-4 levels between the groups in this specific study. researchgate.netnih.gov
Table 2: Effects of this compound as Adjuvant Therapy in Acute-Extrinsic Atopic Dermatitis
Parameter | This compound Group Change vs. Control Group | Statistical Significance (p-value) |
SCORAD Changes | Significant Improvement | <0.001 (Weeks 4, 6, 8), 0.004 (Week 2) researchgate.netnih.gov |
Objective SCORAD Changes | Significant Improvement | <0.001 (Weeks 4, 6, 8), 0.004 (Week 2) researchgate.netnih.gov |
IgE Level Changes | Significant Reduction | 0.002 (Week 8) researchgate.netnih.gov |
IFN-γ Levels | No Significant Change | Not significant researchgate.netnih.gov |
IL-12 Levels | No Significant Change | Not significant researchgate.netnih.gov |
IL-4 Levels | No Significant Change | Not significant researchgate.netnih.gov |
Erythropoietic Protoporphyria and X-linked Protoporphyria
This compound has gained attention as a possible treatment for erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP), collectively known as the protoporphyrias. nih.govporphyria.orgcenterwatch.comresearchgate.netdrugbank.comresearchgate.net These genetic disorders of heme biosynthesis lead to the accumulation of protoporphyrin IX (PPIX), causing severe photosensitivity. porphyria.orgcenterwatch.comresearchgate.netresearchgate.net
The potential role of this compound in treating protoporphyrias is based on the hypothesis that it might inhibit delta-aminolevulinate synthase (ALAS), the first enzyme of heme biosynthesis, thereby reducing PPIX production. centerwatch.comresearchgate.net This inhibitory effect was initially observed in vitro. centerwatch.com Case reports have anecdotally suggested a benefit in EPP. centerwatch.com
An FDA-sponsored research study is currently assessing whether oral this compound administration reduces PPIX levels and impacts photosensitivity in patients with EPP or XLP. porphyria.orgcenterwatch.com This study is a prospective, blinded, randomized, 2x2 cross-over trial comparing this compound to placebo. centerwatch.com Efficacy is being evaluated based on protoporphyrin levels, photosensitivity, and quality of life questionnaires. centerwatch.com A recent study in Denmark also indicated the potential for this compound to lower PPIX in patients with EPP. porphyria.org While some reports have described apparent beneficial effects, concerns have been raised regarding the evidence base, highlighting the need for controlled studies. researchgate.net
Antiviral Properties and Mechanisms
This compound and other H2 receptor antagonists have shown potential in inhibiting various viruses. researchgate.net The proposed antiviral mechanisms of this compound are thought to involve its immunomodulatory properties, which can reverse histamine-mediated immunosuppression by stimulating the effector functions of T and B cells. jmir.org
Research in Herpesvirus Infections
Small studies have investigated the use of this compound in patients with herpesvirus infections, including herpes simplex virus (HSV) and herpes zoster. jmir.org this compound has also been explored for its possible antiviral effect in measles, another viral infection, with one study suggesting it might provide a sooner recovery from symptoms. mikrobiyolbul.org While some reports suggest this compound can treat patients with chronic Epstein-Barr virus (EBV) reactivation, its efficacy in associated neurological disorders has not been confirmed. frontiersin.org this compound has also been mentioned in the context of drug interactions with antiviral medications like famciclovir, used for herpesvirus infections. tandfonline.com In some studies involving the treatment of chronic fatigue syndrome potentially linked to herpesviruses, this compound was sometimes administered alongside antiviral therapy (like acyclovir or valacyclovir) to potentially increase serum levels of the antiviral by inhibiting tubular secretion. dovepress.comscholaris.ca
Investigational Use in Viral Infections (e.g., SARS-CoV-2)
Given prior evidence of antiviral activity against other viruses, including anti-SARS-CoV activity, this compound has been considered for investigational use in viral infections such as SARS-CoV-2. researchgate.net The potential for repurposing existing drugs like this compound for urgent clinical needs, such as the COVID-19 pandemic, has been highlighted due to their established safety profiles, affordability, and accessibility. jmir.orgjmir.org
Molecular Docking and Dynamics Studies with Viral Proteins
Molecular docking studies have been conducted to explore the potential interaction of this compound with SARS-CoV-2 viral proteins. These studies aim to understand the molecular basis for any potential efficacy against the virus. Molecular docking results have shown that this compound, along with other H2 receptor antagonists like famotidine, can bind to SARS-CoV-2 structural proteins. researchgate.net Specifically, studies involving molecular docking and dynamics simulations have suggested that this compound could inhibit SARS-CoV-2 replication by binding to non-structural proteins, including NSP3, NSP7/8 complex, and NSP9. researchgate.netnih.gov Results from these in silico studies indicated that this compound exhibited a higher binding affinity to these viral proteins compared to other H2RAs like nizatidine and ranitidine. researchgate.netnih.gov Molecular dynamic simulations further revealed that this compound binds to these non-structural proteins with high stability over a simulated period of 100 nanoseconds. researchgate.netnih.gov The ability of this compound to bind NSP3 may potentially prevent this protein from acting as a scaffold, thereby hindering its interaction with itself and other viral NSPs and potentially halting viral replication. nih.gov Kinase enrichment analysis has also predicted the involvement of genes such as ERKs, SMADs, and MAPKs in the potential antiviral activity of this compound against SARS-CoV-2. researchgate.net
Data from Molecular Docking and Dynamics Studies (Illustrative Example based on search results):
Compound | Target SARS-CoV-2 Protein | Binding Affinity (kcal/mol) | Stability in MD Simulation (100 ns) |
This compound | NSP3 | Higher than some H2RAs | High |
This compound | NSP7/8 Complex | Higher than some H2RAs | High |
This compound | NSP9 | Higher than some H2RAs | High |
Famotidine | NSP3 | Higher than some H2RAs | High |
Famotidine | NSP7/8 Complex | Higher than some H2RAs | High |
Famotidine | NSP9 | Higher than some H2RAs | High |
Note: Specific numerical binding affinity values varied across different studies and methods. The table above summarizes the comparative findings. researchgate.netnih.gov
Other Investigational Clinical Contexts
Stress Ulcer Prophylaxis Research
Research has explored the use of this compound for stress ulcer prophylaxis, particularly in high-risk patients such as those in intensive care units or those with severe burns. cochranelibrary.comdtic.mil Stress-induced ulcers, like Curling's ulcers in burn patients, are related to a defect in the mucosal barrier often exacerbated by ischemia, hypotension, sepsis, and hypoxia. dtic.mil Early prophylactic administration of this compound, sometimes in combination with antacids, has been shown to significantly reduce the occurrence of complications from these lesions. dtic.mil Experimental studies, including those in rats, have indicated that this compound can prevent the occurrence of stress ulcers. journals.co.za While this compound and other H2-antagonists fulfill many criteria for an ideal stress ulcer prophylaxis drug, clinically significant bleeding can still occur during their use. google.com Studies have compared this compound to other agents like sucralfate for stress ulcer prophylaxis in specific patient populations, such as thermally injured patients. google.com
Data from a Stress Ulcer Prophylaxis Study (Illustrative Example based on search results):
Treatment Group | Stress Ulcer Occurrence |
This compound | Decreased |
Control | Higher |
Note: This table represents findings from experimental studies where this compound showed a decrease in stress ulcer occurrence compared to control groups. journals.co.za
Interstitial Cystitis/Bladder Pain Syndrome: Histamine Receptor Blockade in Bladder Wall
This compound, as a histamine H2-receptor antagonist, has been investigated for the treatment of Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS), a chronic condition characterized by bladder pain or discomfort in the absence of infection. uspharmacist.comemjreviews.comfrontiersin.org The rationale for using this compound in IC/BPS is based on the theory that histamine plays a role in the pathophysiology of the condition, potentially through its effects on the bladder wall. uspharmacist.comemjreviews.com Increased numbers of activated bladder mast cells, which release inflammatory mediators like histamine, have been repeatedly reported in patients with IC/BPS. By blocking histamine H2 receptors, this compound aims to mitigate the effects of histamine in the bladder wall. uspharmacist.comemjreviews.com Evidence supporting the use of this compound in IC/BPS comes from small observational trials and randomized controlled trials. uspharmacist.comemjreviews.com Studies have reported that this compound was statistically significant compared to placebo in improving total symptoms, including pain and nocturia, after several months of treatment. uspharmacist.com Observational studies have also indicated that a percentage of patients report clinically significant improvement in symptoms with this compound. uspharmacist.com While some studies showed symptom relief, histological changes in the bladder mucosa were not consistently observed.
Data from Interstitial Cystitis/Bladder Pain Syndrome Studies (Illustrative Examples based on search results):
Study 1: Randomized Controlled Trial uspharmacist.com
Treatment | Symptom Improvement (Pain and Nocturia) | Statistical Significance vs. Placebo |
This compound | Improved | Yes (after 3 months) |
Placebo | - | - |
Study 2: Observational Studies uspharmacist.com
Dosage Regimen | Percentage of Patients Reporting Significant Improvement |
300 mg twice daily | 44-57% |
200 mg three times daily | 44-57% |
Cimetidine's Interactions with Biological Systems and Other Therapeutics: Mechanistic Studies
Pharmacokinetic Drug-Drug Interactions
Cimetidine is a well-known perpetrator of pharmacokinetic drug-drug interactions, primarily by affecting the metabolism and excretion of other drugs. drugbank.commdedge.com
Impact on Metabolism of Co-administered Drugs via CYP Inhibition
This compound is a potent inhibitor of several cytochrome P450 (CYP) enzymes in the liver. mdedge.comwikipedia.orgnih.gov This inhibition is often competitive and reversible, although mechanism-based irreversible inhibition has also been identified for certain isoforms like CYP2D6. wikipedia.org By inhibiting these enzymes, this compound can reduce the metabolic clearance of drugs that are substrates for these CYP isoforms, leading to increased plasma concentrations and potentially enhanced pharmacological effects or toxicity. drugbank.commdedge.comnih.gov The primary CYP isoforms inhibited by this compound include CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4, with notable inhibition of CYP1A2, CYP2D6, and CYP3A4. wikipedia.org
Specific Examples: Warfarin, Theophylline, Phenytoin, Carbamazepine, Opioid Analgesics, Tricyclic Antidepressants, Lidocaine, Benzodiazepines, Ketoconazole, Itraconazole, Tamoxifen, Codeine, Tramadol
This compound's CYP inhibitory effects lead to clinically significant interactions with numerous drugs:
Warfarin: this compound inhibits the hepatic metabolism of warfarin, particularly the less potent R-warfarin enantiomer, which can increase its anticoagulant effect. mdedge.comnih.govdrugs.comdrugs.com This interaction necessitates monitoring of prothrombin time or International Normalized Ratio (INR) when co-administered. drugs.com
Theophylline: this compound significantly reduces the clearance of theophylline, a substrate of CYP1A2, leading to increased serum concentrations and potential toxicity. mdedge.comwikipedia.org
Phenytoin: this compound has been shown to increase steady-state phenytoin concentrations by inhibiting its metabolism, likely through CYP inhibition. mdedge.com
Carbamazepine: this compound can enhance the metabolism of opioids that rely on hepatic metabolism, and carbamazepine is listed among drugs whose metabolism can be affected. nih.gov
Opioid Analgesics: this compound may increase the effects of opioid analgesics by increasing their duration of action, primarily through inhibition of CYP enzymes involved in their metabolism, such as CYP3A4. nih.govdovepress.com
Tricyclic Antidepressants: this compound can elevate the levels of tricyclic antidepressants like imipramine and nortriptyline by inhibiting their metabolism (demethylation and hydroxylation), increasing the likelihood of adverse effects. wikipedia.orgstatpearls.comnih.gov
Lidocaine: this compound can alter the metabolism of lidocaine, leading to increased plasma concentrations. mdedge.comnih.gov
Benzodiazepines: this compound can decrease the metabolism of certain benzodiazepines, such as alprazolam and bromazepam, potentially increasing their serum levels and effects by affecting CYP3A4 metabolism. mdedge.comwikipedia.orgmedscape.com
Ketoconazole and Itraconazole: this compound reduces the absorption of these antifungal agents because they require a low gastric pH for dissolution and absorption, and this compound increases gastric pH. mdedge.comwikipedia.org
Tamoxifen: this compound may decrease the effects of tamoxifen, which is a prodrug activated by CYP2D6, by inhibiting its metabolism to the active metabolite. wikipedia.org
Codeine: this compound can increase the level or effect of codeine by affecting hepatic enzyme CYP2D6 metabolism, which is responsible for converting codeine to its active metabolite, morphine. wikipedia.orgmedscape.comdrugbank.com This can prevent the conversion of codeine to morphine. medscape.com
Tramadol: Similar to codeine, this compound may decrease the effects of tramadol, a prodrug metabolized by CYP2D6, by inhibiting its activation. wikipedia.org
Influence on Renal Excretion of Other Drugs (e.g., Metformin, Procainamide)
This compound can also interfere with the renal excretion of certain drugs by inhibiting renal tubular transport mechanisms. drugbank.commdedge.com This primarily involves competitive inhibition of organic cation transporters (OCTs) and multidrug and toxin extrusion (MATE) transporters in the renal tubules, which are responsible for the active secretion of cationic drugs into the urine. drugbank.commdpi.comnih.govacs.org
Metformin: this compound inhibits the renal excretion of metformin, a substrate for OCT2 and MATE transporters, leading to increased circulating levels of metformin. wikipedia.orgmdpi.comnih.govacs.orgnih.gov Studies have shown a significant increase in metformin plasma concentrations and a reduction in its renal clearance when co-administered with this compound. nih.govnih.gov This interaction is considered a classical example of a renal cation transporter-mediated drug-drug interaction. acs.org
Procainamide: this compound inhibits the renal clearance of procainamide, which is secreted by an active transport mechanism in the proximal tubule. mdedge.comnih.govnih.govnih.gov This inhibition can lead to increased plasma concentrations and decreased renal clearance of procainamide and its metabolite, N-acetylprocainamide. nih.govnih.gov
Effects on Gastric pH and Drug Absorption Alterations
As an H2 receptor antagonist, this compound reduces gastric acid secretion, leading to an increase in gastric pH. nih.govpatsnap.comnih.gov This alteration in gastric pH can affect the absorption of drugs whose solubility or stability is pH-dependent. medscape.compatsnap.comnih.gov
For drugs that require an acidic environment for dissolution and absorption (e.g., ketoconazole, itraconazole), the increased gastric pH caused by this compound can lead to decreased absorption and reduced bioavailability. mdedge.comwikipedia.orgnih.govacs.org Conversely, the absorption of some drugs whose absorption is normally decreased by acid inactivation in the stomach might be increased. nih.gov However, the clinical significance of this compound's effect on gastric pH on drug absorption has not always been definitively established for all interacting drugs. nih.gov
Pharmacodynamic Interactions
While primarily known for pharmacokinetic interactions, this compound has also been explored for potential pharmacodynamic interactions, particularly in the context of immunomodulation and cancer therapy.
Potential Attenuation of Anti-PD-1/PD-L1 Therapeutic Effects
Studies suggest that this compound may have the potential to attenuate the therapeutic effects of anti-PD-1 and anti-PD-L1 therapies, which are a class of immune checkpoint inhibitors used in cancer treatment. The programmed cell death protein 1 (PD-1) and its ligand (PD-L1) pathway is a critical immune checkpoint that, when activated, suppresses T-cell function, allowing cancer cells to evade immune surveillance. Inhibitors targeting this pathway aim to restore anti-tumor immunity. frontiersin.orgwikipedia.orgexplorationpub.com
Research in colon cancer models has investigated the combined effects of this compound with anti-PD-1 and anti-PD-L1 antibodies. In an in vivo study using BALB/c mice implanted with CT26 colon adenocarcinoma cells, while anti-PD-1 and anti-PD-L1 suppressed tumor growth, this compound showed only mild anti-tumor activity on its own. researchgate.netnih.govnih.gov Crucially, when this compound was administered in combination with either anti-PD-1 or anti-PD-L1, it significantly attenuated their anti-tumor effects. researchgate.netnih.govnih.gov
Further investigation into the tumor microenvironment revealed that anti-PD-L1 treatment increased the presence of CD3+, CD4+, and CD8+ T cells, as well as M1 macrophages, all of which are associated with anti-tumor immunity. researchgate.netnih.gov However, combined treatment with this compound reversed this increase in these immune cell populations. researchgate.netnih.gov this compound also reversed the decrease in circulating and tumor-associated neutrophils induced by anti-PD-1 and anti-PD-L1, suggesting a modulation of the immune cell landscape that may counteract the effects of checkpoint inhibition. researchgate.netnih.gov
The mechanism underlying this attenuation is not fully elucidated but may involve this compound's interference with histamine-mediated immunomodulation, potentially through its action on histamine H2 receptors which are present on various immune cells. researchgate.netnih.govnih.gov
Interactions with Endogenous Systems
This compound has been shown to interact with endogenous hormonal systems, particularly the hormonal axes regulating sex hormones. These interactions contribute to its observed antiandrogenic and potential estrogenic activities.
Antiandrogenic and Estrogenic Activities: Research on Hormonal Axes
This compound exhibits weak antiandrogenic activity, primarily through its ability to competitively antagonize the androgen receptor (AR), the target of androgens like testosterone and dihydrotestosterone (DHT). wikipedia.orgnih.govoup.com Although its affinity for the AR is considerably weaker than that of endogenous androgens, this interaction can lead to antiandrogenic effects, particularly at higher doses or during long-term treatment. wikipedia.orgnih.gov
Research also indicates that this compound can influence estrogen levels. This effect is thought to be primarily mediated by the inhibition of cytochrome P450 enzymes involved in the metabolism of estradiol, specifically inhibiting the 2-hydroxylation of estradiol in the liver. wikipedia.orgajol.inforesearchgate.net This inhibition can lead to decreased degradation of estradiol and consequently increased serum estradiol levels. wikipedia.orgajol.inforesearchgate.net An additional proposed mechanism for increased estradiol levels is the potential for increased conversion of testosterone to estrogen, particularly in the presence of elevated testosterone levels induced by this compound treatment. ajol.info
The interplay between these antiandrogenic and estrogenic effects can contribute to hormonal imbalances.
Effects on Testosterone Biosynthesis and Estradiol Hydroxylation
Studies have investigated the direct effects of this compound on testosterone biosynthesis and estradiol hydroxylation. While some reports suggest this compound may reduce testosterone biosynthesis in individual cases, the primary impact appears to be related to its antiandrogenic properties and effects on estradiol metabolism. wikipedia.orgaacrjournals.org
Inhibition of estradiol 2-hydroxylation by this compound has been demonstrated, leading to increased serum estradiol concentrations. wikipedia.orgajol.inforesearchgate.net This mechanism is considered a significant factor in the observed estrogenic effects of this compound. wikipedia.orgajol.inforesearchgate.net
Research in male rats administered this compound showed a significant increase in serum testosterone levels, alongside increases in FSH and estradiol. ajol.info This increase in testosterone is potentially linked to the antiandrogenic properties of this compound, which may lead to a loss of negative feedback on the hypothalamic-pituitary-gonadal (HPG) axis, thereby stimulating gonadotropin release (like LH and FSH) which, in turn, can increase testosterone production. wikipedia.orgajol.info However, other studies in male rats have reported decreased testosterone levels with this compound treatment, highlighting variability in findings potentially related to dose and study duration. ijpbms.com
Prolactin Level Modulation
This compound has been associated with increased serum prolactin levels. wikipedia.orgaacrjournals.orgnih.govijpbms.com This effect is thought to be related to its action as a histamine H2 receptor antagonist, as H2 receptors are involved in the regulation of prolactin secretion. nih.govijpbms.comdovepress.com High doses of this compound have been particularly linked to elevated prolactin levels. nih.govijpbms.com
Studies in healthy volunteers have shown that intravenous administration of this compound can acutely raise serum prolactin levels. researchgate.netnih.gov The mechanism may involve a reduced dopaminergic inhibition of pituitary lactotrophs, the cells responsible for prolactin production, as dopamine is a known inhibitor of prolactin release. researchgate.netnih.gov
Research on Reproductive System Effects in Male Models
Research in male animal models, particularly rats, has provided insights into the effects of this compound on the reproductive system. This compound has been classified as a reproductive toxicant in male rats, with studies documenting adverse effects on testicular structure and function. idosr.orgoup.comoup.comresearchgate.netnih.gov
Observed effects in male rat models include decreased sperm motility, count, and viability, as well as an increase in abnormal sperm morphology. ijpbms.comidosr.org Histological examinations of testicular tissue have revealed structural abnormalities, such as degeneration of seminiferous tubules, reduced tubular diameter, and increased apoptotic germ cells. idosr.orgoup.comoup.comresearchgate.netnih.gov
The mechanisms underlying this compound-induced reproductive toxicity in male models are complex and may involve multiple factors, including hormonal imbalances, direct effects on testicular cells (such as peritubular cells), and induction of apoptosis. idosr.orgoup.comoup.comresearchgate.netnih.govspandidos-publications.com
Here is a summary of some research findings on this compound's effects on hormone levels in male models:
Study Model | This compound Dose/Duration | Observed Effect on Testosterone | Observed Effect on FSH | Observed Effect on LH | Observed Effect on Estradiol |
Male Wistar Rats | Therapeutic dose, chronic | Increased | Increased | No change | Increased |
Male Wistar Rats | 120 mg/kg/day, 9 weeks | Significantly Higher | Not specified | Significantly Higher | Not specified |
Male Wistar Rats | Not specified | Fell | Fell | Rose | Not specified |
Male Rats | 50 mg/kg or 250 mg/kg, 59 days | Unchanged | Significantly Elevated | Not specified | Not specified |
Male Rats | 100mg/kg B.W., 38 days | Significantly decrease | Significantly decrease | Increase | Not specified |
Healthy Male Humans | 1000 mg/day for 3 months, then 400 mg nocte for 3 months | Elevated | Increased | Unchanged | Not specified |
Healthy Male Volunteers | 300 mg four times daily, 6 weeks | No change | Not altered | Decreased | Lower after discontinuation |
Note: This table summarizes findings from different studies with varying methodologies and may not represent a direct comparison across all parameters within a single study. ajol.infoijpbms.comoup.comnih.govspandidos-publications.comnih.govumich.edu
Advanced Research on Adverse Effects and Toxicological Mechanisms of Cimetidine
Central Nervous System Effects: Mechanisms of Headache, Dizziness, Somnolence, Delirium
Cimetidine has been associated with central nervous system (CNS) effects such as headache, dizziness, somnolence, confusion, and delirium. cambridge.orgnih.govmedcentral.compatsnap.comwebmd.com These effects may be more pronounced in elderly patients or those with pre-existing renal or hepatic impairment. nih.govmedcentral.comwebmd.com The exact mechanisms are not fully elucidated, but interactions with cerebral H2 receptors are suggested to play a role. cambridge.org this compound can cross the blood-brain barrier. cambridge.org Some studies suggest that the increased distribution of this compound in cerebrospinal fluid in individuals with severe hepatic dysfunction may contribute to confusion, indicating a potential link between impaired metabolism/excretion and CNS toxicity. cambridge.org Research indicates that these confusional states typically occur within 2-3 days of starting this compound and resolve within 3-7 days after discontinuation. medcentral.com
Endocrine System Research: Mechanisms of Gynecomastia and Impotence
Endocrine-related adverse effects, including gynecomastia (breast enlargement in men) and impotence (erectile dysfunction), have been linked to this compound, particularly with long-term or high-dose use. nih.govwikipedia.orgelsevier.es Research points to antiandrogenic effects as a primary mechanism. wikipedia.orgelsevier.esfrontiersin.orgresearchgate.net this compound is thought to block androgen receptors (ARs), particularly in breast tissue, leading to unopposed estrogen action. wikipedia.org Another proposed mechanism involves the inhibition of estrogen metabolism, which could result in increased estrogen levels. nih.govwikipedia.org Studies have shown that this compound can decrease the 2-hydroxylation of estradiol, leading to increased serum estradiol concentrations, which may contribute to symptoms of estrogen excess like gynecomastia. nih.gov High doses of this compound (over 5 g/day ) have been associated with reversible impotence or gynecomastia. nih.gov This effect may also be related to an increase in prolactin levels, potentially due to histamine H2 receptor blockade and non-specific stimulation of prolactin secretion. nih.gov
Hepatic Effects: Mechanisms of this compound-Induced Hepatitis
This compound is generally associated with a low incidence of hepatic effects. nih.govwikipedia.org Transient elevations in aminotransferase activity are more common, while overt hepatotoxicity is rare. wikipedia.orgnih.gov The mechanism of this compound-induced hepatitis is not fully understood but is suggested to involve a hypersensitivity-type reaction. nih.govnih.govnih.gov Some research indicates that injury may result from the activation of this compound to a toxic intermediate, potentially through its metabolism by and inhibition of hepatic microsomal P450 enzymes. nih.gov Rapid recurrence upon rechallenge is characteristic, although features of hypersensitivity are not always prominent. nih.gov Hepatic injury is usually reversible upon discontinuation of the drug. nih.gov
Renal Effects: Mechanisms of Elevated Serum Creatinine
An increase in plasma creatinine concentration is a known effect of this compound. scispace.comonderzoekmetmensen.nlmdpi.comnih.gov This elevation is primarily attributed to competition between this compound and creatinine for renal tubular secretion, rather than a decrease in glomerular filtration rate (GFR). scispace.comonderzoekmetmensen.nlmdpi.comresearchgate.net this compound inhibits the tubular secretion of creatinine by competing for transport pathways, specifically the organic cation transporter OCT2 and multidrug and toxin extrusion transporters (MATE) in the proximal tubules. mdpi.comresearchgate.net Studies have shown that while creatinine clearance may decrease, GFR measured by other markers like inulin or 51Cr-EDTA remains largely unaffected, particularly with long-term use. scispace.commdpi.comnih.govresearchgate.net The increase in serum creatinine is typically observed shortly after initiating treatment and is reversible upon discontinuation. scispace.comnih.gov
Data Table: Effect of this compound on Renal Function Markers
Marker | Change with this compound | Proposed Mechanism | Source |
Plasma Creatinine | Significantly increased (early and later stages) | Competition for renal tubular handling | scispace.com |
Creatinine Clearance | Significantly reduced (early, returns to baseline later) | Competition for renal tubular handling | scispace.comresearchgate.net |
GFR (measured by 51Cr EDTA) | Significantly reduced (early, returns to baseline later) | Early, short-lived fall in GFR and renal plasma flow | scispace.com |
GFR (measured by Inulin) | No significant change | This compound inhibits tubular secretion, not filtration | mdpi.comresearchgate.net |
Note: This table summarizes findings from different studies and may reflect variations in dosage, duration, and patient populations.
Hematological Effects: Research on Agranulocytosis
Hematological abnormalities, including agranulocytosis (a severe reduction in the number of granulocytes), have been reported rarely in association with this compound. scispace.comnih.goviarc.fr While rare, a fatal case of agranulocytosis linked to this compound has been reported. nih.gov The possible mechanisms underlying granulocytopenia are not fully established, but an idiosyncratic reaction is suggested as a potential cause of bone marrow suppression. nih.gov Agranulocytosis can result from inadequate granulopoiesis or accelerated destruction of neutrophils. nih.gov However, establishing a definitive causal link between this compound and agranulocytosis can be challenging due to the multifactorial possibilities for bone marrow suppression. nih.gov
Hypersensitivity Reactions
This compound can cause hypersensitivity reactions, although severe reactions are rare. frontiersin.orgconfex.com These reactions can include urticaria and angioedema. wikipedia.org An IgE-dependent mechanism has been suggested for hypersensitivity induced by H2-receptor antagonists. confex.com Additional research has linked this compound to an increase in Th1-type cytokine-mediated immune responses and delayed-type hypersensitivity reactions. springermedizin.de Studies in mice have shown that this compound can enhance allergic contact hypersensitivity, potentially by inhibiting the induction of T-suppressor cells. nih.gov While this compound is sometimes used as an adjunct in treating allergic reactions, it can paradoxically induce severe reactions, including anaphylaxis. researchgate.net Cross-reactivity among different H2-receptor antagonists has also been reported. confex.comresearchgate.net
Mechanisms of Male Reproductive System Toxicity
Research indicates that this compound can induce toxicity in the male reproductive system, potentially leading to reduced sperm count, motility, and morphology, as well as testicular damage. elsevier.esfrontiersin.orgoup.com These effects are linked to the antiandrogenic properties of this compound. elsevier.esfrontiersin.org Studies in rats have shown that this compound can cause a reduction in serum testosterone levels, associated with Leydig cell apoptosis and reduced steroidogenesis. frontiersin.org This androgenic dysfunction is believed to contribute to germ cell loss and Sertoli cell apoptosis. frontiersin.org this compound has been shown to disrupt the hypothalamic-pituitary-testicular axis, leading to hormonal imbalances such as elevated luteinizing hormone (LH) and testosterone, alongside reduced follicle-stimulating hormone (FSH). oup.comresearchgate.netspandidos-publications.comnih.gov Histological studies in rats have revealed testicular lesions, including changes in seminiferous tubules and increased apoptotic cells, potentially associated with the upregulation of COX-2, iNOS, and NF-κB. researchgate.netspandidos-publications.comnih.gov this compound's interference with peritubular tissue and Sertoli cell function may also contribute to tubular alterations. elsevier.es
Testicular Histoarchitecture Alterations
Research indicates that this compound administration negatively impacts the structural integrity of the testes, leading to significant histopathological changes. Studies in male rats have observed considerable alterations in testicular histoarchitecture, including distortions in the seminiferous tubules idosr.orgnih.gov. These structural changes can involve the degeneration of seminiferous tubules, which are crucial for supporting normal spermatogenesis oup.comoup.com. Histological examinations have revealed irregular tubules, disordered epithelium, and intraepithelial vacuolization oup.comresearchgate.net. Furthermore, a reduction in tubular diameter and epithelial area has been noted, attributed to the detachment and loss of germ cells elsevier.es.
Studies have also pointed to effects on the peritubular tissue. Reduced peritubular tissue volume and the presence of apoptotic peritubular cells suggest that these cells are a primary target of this compound toxicity oup.comresearchgate.netoup.com. Investigations have also demonstrated that this compound can induce testicular microvasculature atrophy, characterized by a significant decrease in microvascular density and vascular luminal area, along with collapsed blood vessel profiles elsevier.esnih.govresearchgate.netresearchgate.net. This vascular impairment is thought to contribute to the structural disruption of the seminiferous tubules elsevier.es.
Spermatogenesis Impairment and Apoptosis Induction
This compound has been shown to impair spermatogenesis, the process of sperm production, in male subjects and animal models. This impairment is closely linked to the observed histoarchitecture alterations and the induction of apoptosis in various testicular cell populations. Studies have reported significant declines in sperm count, motility, and morphology in men treated with this compound oup.comresearchgate.net. In rat models, this compound administration has resulted in decreased sperm quality, including reduced sperm motility and count idosr.orgnih.govelsevier.es.
The drug is recognized as an inducer of apoptosis, a programmed cell death mechanism, in testicular cells oup.com. Apoptotic changes have been highlighted in peritubular cells and spermatogenic cells oup.comresearchgate.net. The loss of germ cells by apoptosis contributes to the reduction in the epithelial area of the seminiferous tubules elsevier.es. TUNEL labeling, a technique to detect apoptotic cells, has confirmed extensive apoptotic cell death in peritubular cells and vascular smooth muscle cells within the testes of this compound-treated rats oup.comnih.govresearchgate.netnih.gov. This apoptosis in vascular cells leads to testicular vascular atrophy nih.govresearchgate.netresearchgate.net.
Studies have also observed maturation arrest of spermatogenic cells idosr.orgresearchgate.net. The impairment of peritubular cells, which provide structural and nutritional support for developing sperm, and the apoptosis of spermatogenic cells contribute to compromised sperm production oup.comresearchgate.net.
Below is a table summarizing some research findings on the effects of this compound on sperm parameters:
Study | Species | This compound Dose/Duration | Observed Effects on Sperm Parameters |
Ngozi et al. idosr.orgnih.gov | Wistar rats | 60 mg/kg for 28 days | Deleterious alterations to sperm motility, count, and viability. |
Aprioku, Ibeachu, and Ijeomah idosr.org | Wistar rats | Significant and dose-dependent decrease in sperm count and motility; no change in morphology or viability. | |
Xu et al. idosr.orgresearchgate.net | Wistar rats | 120 mg/kg/day for 9 weeks | Significantly decreased average path velocity, straight line velocity, and curvilinear velocity. |
Source | Piroxicam ulcerated rats | This compound administration | Significant reduction in epididymal sperm count and motility. |
Source nih.gov | Men with chronic duodenal ulcer | 1000 mg/day for 3 months, then 400 mg nocte for 3 months | Mean sperm count lower during therapy; motility and morphology not affected. |
Hormonal Imbalance in Male Reproductive Axis
This compound can disrupt the delicate balance of the hypothalamic-pituitary-testicular axis, a key regulator of male reproductive function, leading to hormonal imbalances oup.comoup.comresearchgate.net. Studies have documented alterations in the levels of key reproductive hormones.
Research in male rats has shown that this compound administration can lead to changes in hormonal levels, confirming an antiandrogenic effect elsevier.esunesp.br. Some studies have reported elevated luteinizing hormone (LH) and testosterone levels idosr.orgresearchgate.net. However, other research indicates concurrently reduced levels of follicle-stimulating hormone (FSH) and testosterone oup.comoup.com. In one study on men, testosterone levels were found to be elevated during therapy, while serum LH remained unchanged and FSH was increased nih.gov. Some individual case reports suggest that this compound may reduce testosterone biosynthesis and increase prolactin levels, potentially secondary to increased estrogen levels wikipedia.org. At typical therapeutic levels, this compound may have no effect or cause small increases in circulating testosterone, possibly due to the loss of negative feedback on the HPG axis resulting from androgen receptor antagonism wikipedia.org.
This compound is known to exert antiandrogenic effects by antagonizing androgen receptors and potentially inhibiting the conversion of testosterone to dihydrotestosterone (DHT) oup.comresearchgate.net. This interference with androgen signaling pathways can impair spermatogenesis and contribute to reduced sperm quality oup.comresearchgate.net.
Below is a table summarizing some research findings on the effects of this compound on male reproductive hormones:
Study | Species | This compound Administration | Observed Effects on Hormone Levels |
Ngozi et al. idosr.orgnih.gov | Wistar rats | 60 mg/kg for 28 days | Derangements in plasma levels of FSH, LH, and testosterone. |
Xu et al. idosr.orgresearchgate.net | Wistar rats | 120 mg/kg/day for 9 weeks | Luteinizing hormone and testosterone levels significantly higher compared to control. |
Luiz et al. idosr.orgoup.comnih.gov | Rats | 50 mg/kg or 250 mg/kg for 59 days | FSH level significantly elevated; testosterone levels unchanged. |
Source oup.comoup.comresearchgate.net | Not specified (Review) | This compound administration | Elevates LH while concurrently reducing levels of FSH and testosterone. |
Source nih.gov | Men with chronic duodenal ulcer | 1000 mg/day for 3 months, then 400 mg nocte for 3 months | Testosterone levels elevated; serum LH unchanged; FSH increased; serum PRL levels increased in some subjects. |
Source wikipedia.org | Not specified (Review) | Long-term treatment | Rarely may cause sexual dysfunction due to hormonal effects; may reduce testosterone biosynthesis and increase prolactin in case reports; typical doses may have no effect or small increases in testosterone. |
Methodological Approaches and Future Directions in Cimetidine Research
Preclinical Research Methodologies
Preclinical studies are fundamental to understanding the biological effects of cimetidine at the cellular and organismal levels before human trials. These methodologies provide insights into its pharmacological activities, potential toxicities, and underlying molecular interactions.
In Vitro Studies (e.g., Cell Adhesion Assays, Microsomal Studies)
In vitro studies utilize isolated biological components, such as cells or enzymes, to investigate specific interactions with this compound. Cell adhesion assays, for instance, can be used to explore this compound's potential effects on cellular interactions, which is relevant in contexts like cancer metastasis. Microsomal studies are crucial for understanding how this compound interacts with drug-metabolizing enzymes, particularly cytochrome P-450 (CYP) enzymes, in the liver.
Early in vitro studies using rat hepatic microsomes indicated that this compound, at millimolar concentrations, could inhibit various CYP-mediated enzyme activities in a seemingly reversible manner. ubc.ca However, these concentrations were significantly higher than typical serum concentrations observed in both rats and humans. ubc.ca More detailed in vitro investigations have shown that this compound can inhibit the O-deethylation of 7-ethoxycoumarin in rat liver microsomes. nih.gov This inhibition was more pronounced when this compound was preincubated with the microsomes in the presence of an NADPH-generating system before the substrate was added. nih.gov This preincubation also led to a decrease in cytochrome P-450 content, suggesting the involvement of an activated complex with the enzyme. nih.gov Studies have also explored the effect of this compound on specific CYP isoforms like CYP1A1 and CYP2C6 in rat hepatic microsomes. medicinacomplementar.com.br Preincubation of microsomes from uninduced rats with this compound and NADPH in vitro increased the potency of inhibition of EROD activity by 20-fold, suggesting that this compound inhibits CYP2C6 by forming a metabolite/intermediate complex, similar to its interaction with CYP2C11. medicinacomplementar.com.br
In the context of cancer research, in vitro studies have examined the direct effects of this compound on cancer cell lines. For example, studies on colon adenocarcinoma CT26 cells investigated the impact of this compound on cell viability, clonogenicity, and cell cycle distribution. nih.gov An MTT assay was used to measure mitochondrial activity and estimate cell viability. nih.gov While this compound did not show a significant effect on cell viability in this specific cell line, it did significantly affect clonogenicity. nih.gov
In Vivo Animal Models (e.g., Mouse Models for Cancer, Rat Models for Reproductive Toxicity, Pharmacokinetics)
In vivo studies using animal models are essential for evaluating the systemic effects of this compound, including its pharmacokinetics, efficacy in complex biological systems, and potential toxicity to various organs.
Mouse and rat models have been extensively used to investigate the potential anti-cancer effects of this compound, often focusing on its immunomodulatory mechanisms. nih.gov Early in vivo results suggested that this compound could enhance the cytotoxic effect of cyclophosphamide in male DBA2 mice injected with P-388 leukaemia cells, leading to a significant increase in survival time. nih.gov However, some challenges in replicating these early findings were reported. nih.gov Research has continued to explore this compound's effects, often in combination with other agents, in various cancer types in animal models, including melanoma, ovarian cancer, colorectal cancer, gastric tumors, pancreatic cancer, lung cancer, and gliomas. nih.gov Additionally, studies in mouse and rat models of bladder cancer have indicated that the anti-angiogenic effect of this compound administration may be linked to reduced expression of platelet-derived endothelial growth factor (PDECGF) and VEGF. nih.gov
Rat models have also been utilized to study the potential reproductive toxicity of this compound. Studies involving oral administration of this compound to male rats at different doses for several weeks have assessed its effects on the reproductive system. researchgate.net Parameters evaluated include sperm parameters (count, viability, morphology) using computer-assisted sperm analysis, serum hormone levels (testosterone, FSH, LH) measured by ELISA, and histological examination of the testes. researchgate.net Findings from such studies have indicated that this compound can lead to a significant decrease in sperm motility, an increase in abnormal sperm morphology, and a decrease in sperm counts at certain doses. researchgate.net Histological examination has revealed testicular lesions, including increased thickness of epithelial cells and diameter of seminiferous tubules, and a reduction in Leydig's cells. researchgate.net
Pharmacokinetic studies in animals help to understand how this compound is absorbed, distributed, metabolized, and excreted. Studies in rats and dogs have shown that the principal metabolite of this compound is the sulfoxide, formed by oxidation of the side-chain sulfur. iarc.fr In rats, this compound has been shown to inhibit hepatic CYP2C6 and CYP2C11 in vivo but not CYP1A1. medicinacomplementar.com.br
Molecular Docking and Molecular Dynamics Simulations
Computational methods like molecular docking and molecular dynamics simulations play a vital role in understanding the interactions between this compound and its target molecules at an atomic level. These techniques can predict binding affinities, identify key interaction sites, and simulate the dynamic behavior of drug-receptor complexes.
Molecular docking studies have been used to investigate the binding of this compound to the human histamine H2 receptor, its primary target. scialert.netbenthamscience.com These studies aim to define the binding sites and identify key amino acid residues involved in the interaction. scialert.netbenthamscience.com For example, Asp98 in transmembrane domain 3 (TM3) has been identified as a major contributor to ligand binding through hydrogen bond interactions. scialert.netbenthamscience.com Asn159 in TM4 and Asp186 in TM5 have also been found to be important in stabilizing the H2 receptor-antagonist complex. benthamscience.com
Molecular dynamics simulations complement docking studies by providing insights into the stability of the drug-receptor complex over time and the conformational changes that occur upon binding. scialert.netbenthamscience.comnih.gov Simulations of this compound bound to the H2 receptor have been performed to validate homology models of the receptor and assess the reliability of docking results. scialert.netbenthamscience.com
More recently, molecular docking and dynamics simulations have been applied to explore the potential of this compound for repurposing against other targets, such as proteins from the SARS-CoV-2 virus. nih.gov Studies have performed molecular docking between this compound and viral non-structural proteins (NSP3, NSP7/8 complex, and NSP9) to assess binding affinity. nih.gov Subsequent molecular dynamics simulations over 100 ns have been conducted to evaluate the stability of the complexes and the efficiency of binding. nih.gov Results from such studies have suggested that this compound could bind to these non-structural proteins with high stability. nih.gov
Clinical Research Designs
Clinical research evaluates the effects of this compound in human subjects, providing evidence for its efficacy and safety in various medical conditions.
Randomized Controlled Trials
Randomized controlled trials (RCTs) are considered the gold standard for evaluating the efficacy of interventions. In RCTs, participants are randomly assigned to receive either this compound or a control (e.g., placebo or another treatment) to minimize bias and allow for robust comparisons of outcomes.
RCTs have been conducted to assess the effectiveness of this compound in treating conditions like dyspepsia, peptic ulcers, and oesophagitis. nih.govtandfonline.com Studies have utilized double-blind, placebo-controlled designs, including single-subject trials and multi-crossover designs, to evaluate the symptomatic relief provided by this compound. nih.govtandfonline.com These trials have shown that this compound can significantly alleviate symptoms compared to placebo in patients with peptic ulcer disease, oesophagitis, and non-ulcer dyspepsia. tandfonline.com
RCTs have also investigated the potential role of this compound in cancer treatment. A randomized, double-blind, placebo-controlled trial by the British Stomach Cancer Group examined the effects of this compound on the survival of patients with gastric cancer. researchgate.net The study randomized patients with early and advanced gastric cancer to receive either this compound or placebo. researchgate.net The primary endpoint was death. researchgate.net
Another area of investigation using RCTs is the potential for this compound in weight management. An open, non-randomized follow-up study of subjects who had completed an 8-week randomized double-blind, placebo-controlled trial of this compound for weight loss explored the long-term effects of intermittent this compound treatment combined with diet and exercise. medscimonit.com
Systematic Reviews and Meta-Analyses
Systematic reviews and meta-analyses synthesize findings from multiple individual studies to provide a comprehensive and often more precise estimate of an intervention's effect. Systematic reviews follow a rigorous process to identify, evaluate, and summarize relevant research, while meta-analyses use statistical methods to combine data from multiple studies.
Systematic reviews have been conducted to assess the evidence for repurposing this compound as a potential immunomodulatory agent against colorectal carcinoma. nih.gov These reviews typically search electronic databases for relevant RCTs that investigated the effects of this compound on survival and immunomodulation, such as improvements in tumor-infiltrating lymphocytes (TILs) and peripheral blood lymphocytes. nih.gov Findings from such reviews have indicated that this compound may offer a survival benefit and exhibit immunomodulatory effects in patients undergoing curative resection for colorectal cancer, although the heterogeneity of studies highlights the need for large-scale, well-designed prospective RCTs. nih.gov
Meta-analyses have also been performed to compare the efficacy of this compound with other treatments for various conditions. For instance, a meta-analysis compared the efficacy of this compound and ribavirin in the treatment of mumps by analyzing controlled trials. bbwpublisher.com The analysis evaluated outcomes such as effective rate and time of swelling regression. bbwpublisher.com Another meta-analysis pooled data from randomized, double-blind, placebo-controlled trials to determine the frequency of adverse reactions among patients treated with this compound for acute acid-peptic disorders. nih.gov
Systematic reviews have also been used to consolidate research findings on the potential of medicinal plants to restore reproductive functionality following this compound-induced reproductive toxicity, assessing their effectiveness, safety, and mechanisms. oup.comoup.com
Here is a summary of some research findings discussed:
Observational Studies and Real-World Evidence
Observational studies and the analysis of Real-World Evidence (RWE) play a crucial role in understanding the usage and potential effects of this compound in diverse patient populations and routine clinical practice settings. RWE is clinical evidence derived from the analysis of Real-World Data (RWD), which is collected from various sources outside of traditional randomized controlled trials (RCTs). frontiersin.orgfda.gov These sources can include electronic health records, disease registries, and claims databases. frontiersin.org
While RCTs are considered the gold standard for establishing efficacy and safety under controlled conditions, RWE offers valuable insights into the performance of drugs in broader, more heterogeneous populations encountered in everyday healthcare. dovepress.com This is particularly relevant for a widely used and long-standing drug like this compound. Observational studies can help assess long-term outcomes, identify potential safety signals, and evaluate the effectiveness of this compound in subgroups of patients who might not be well-represented in clinical trials. dovepress.com
For instance, RWE has been utilized in pharmacovigilance to monitor and quantify adverse drug effects. It can also inform study design and provide insights into the efficacy and safety of health products in real-world settings. frontiersin.org The greatest strength of RWE studies lies in their external validity, allowing for the evaluation of treatment transferability to broader populations.
However, it is important to acknowledge the limitations of observational studies, including the potential for confounding, selection bias, and information bias, especially when attempting to establish causality. Despite these challenges, RWE studies contribute valuable data that complements findings from controlled trials, providing a more comprehensive understanding of this compound's impact in the real world.
Challenges and Limitations in this compound Research
Research involving this compound, particularly in exploring new therapeutic applications, faces several challenges and limitations. These can impact the interpretation and generalizability of study findings.
Heterogeneity in Study Designs
A significant challenge in synthesizing findings from different this compound studies is the considerable heterogeneity in study designs. This variability can manifest in various aspects, including patient populations, treatment durations, dosages (though dosage information is excluded here), and outcome measures. For example, studies investigating the effect of this compound on blood alcohol levels have been criticized for issues such as small sample sizes, heterogeneity of study populations, and variations in the amount and timing of alcohol ingestion, as well as participants' fed or fasted status. nih.gov
Emerging Research Areas and Future Potentials
Emerging research areas for this compound explore its potential applications beyond its established use as an H2 receptor antagonist, particularly focusing on its immunomodulatory and anti-cancer properties.
Repurposing in Oncology and Immune-Related Diseases
One of the most active areas of emerging research for this compound is its potential for repurposing in oncology and immune-related diseases. This compound has demonstrated anti-cancer properties in various preclinical and clinical studies for different cancer types, including colorectal cancer, gastric cancer, melanoma, and renal cell carcinoma. oncology-central.comecancer.orgnih.gov
The proposed mechanisms underlying this compound's anti-cancer effects are multifaceted and include blocking histamine receptors on cancer cells and modulating the immune system's response against cancer. oncology-central.comecancer.org Histamine and its receptors are present in tumor cells and the tumor microenvironment, suggesting their involvement in tumor progression. researchgate.net this compound is thought to support the immune system's defenses against cancer. oncology-central.comecancer.org
Studies have investigated the use of this compound as an adjunct to conventional cancer therapies. For instance, research has explored the use of perioperative this compound in patients undergoing surgical resection of colorectal cancer, with some findings suggesting a potential survival benefit. nih.govnih.gov A systematic review indicated that repurposing this compound has the potential to offer a survival benefit by acting as an immunomodulatory agent in patients undergoing curative resection for colorectal cancer. nih.gov
Beyond oncology, this compound has shown potential in other immune-related conditions, such as demonstrating beneficial effects on cell-mediated immunity following burn injury and alleviating damage induced by irradiation in animal models through antioxidation and immunomodulation. nih.gov Research is also exploring its potential in neurodegenerative diseases like Parkinson's, investigating its ability to attenuate amyloid formation. researchgate.net
Despite promising results, further large-scale, well-designed prospective studies are needed to definitively establish the efficacy of this compound in these emerging areas. nih.gov
Novel Combination Therapies
Another promising future direction for this compound research involves exploring its use in novel combination therapies. Given its diverse mechanisms of action, particularly its immunomodulatory effects, this compound is being investigated for its potential to enhance the effectiveness of other therapeutic agents.
For example, the potential for this compound to synergize with existing chemotherapeutics is being explored. nih.gov Preclinical studies have indicated that this compound could enhance the cytotoxic effect of cyclophosphamide in animal models. nih.gov
Research is also investigating combinations of this compound with other drugs for cancer treatment. A study proposed investigating a combination of phospho-valproic acid and this compound for pancreatic cancer prevention. grantome.com Additionally, the potential of combining this compound with metformin and ibuprofen has been explored in breast cancer models, with some findings suggesting a decrease in tumor size and increased survival rate. scientificarchives.com
However, research into combination therapies also highlights complexities. For instance, a study examining this compound's effect on the anti-cancer effect of anti-PD-L1 in colon cancer noted contradictory effects on immune checkpoint blockade, suggesting the need for careful consideration in developing new combination therapies with immunotherapy. nih.govmdpi.com
The exploration of novel combinations aims to leverage this compound's unique properties to improve therapeutic outcomes, particularly in areas like oncology and immune modulation. Future research will likely focus on identifying optimal drug combinations and understanding the underlying mechanisms of synergy or potential antagonism.
Advanced Mechanistic Elucidation of Non-H2RA Effects
Beyond its well-established role as a histamine H2 receptor antagonist, this compound exhibits a range of non-H2 receptor-mediated effects that have garnered significant research interest, particularly in oncology and immunology. Advanced mechanistic studies are crucial to fully understand these multifaceted actions and pave the way for potential therapeutic repurposing.
One key area of investigation focuses on this compound's immunomodulatory properties. Research indicates that this compound can influence both innate and adaptive immune responses. Methodological approaches to elucidate these effects include in vitro studies using isolated immune cells and in vivo studies utilizing animal models of cancer and immune-related diseases. Techniques such as flow cytometry are employed to assess changes in immune cell populations, including T lymphocytes (CD3+, CD4+, CD8+), natural killer (NK) cells, dendritic cells (DCs), and myeloid-derived suppressor cells (MDSCs). nih.govwaocp.orgnih.gov Enzyme-linked immunosorbent assays (ELISA) and other cytokine profiling methods are used to measure the production of key cytokines, such as IFN-γ, TNF-α, IL-10, and IL-12, which are critical mediators of immune responses. waocp.orgaai.org
Detailed research findings highlight this compound's ability to reverse histamine-mediated immunosuppression, particularly through its action on H2 receptors expressed on various immune cells. nih.gov Studies have shown that this compound can potentiate the effector functions of neutrophils, monocytes, macrophages, DCs, NK cells, NKT cells, Th1, Th2, Th17, and CD8+ cytotoxic T cells. nih.gov Conversely, it has been reported to reduce regulatory/suppressor T cell-mediated immunosuppression. nih.gov For instance, in a mouse model of breast cancer, this compound treatment increased the percentage of splenic Th1 cells and elevated plasma levels of IFN-γ, while reducing plasma levels of TGF-β, a cytokine associated with immunosuppression. waocp.org
Immunomodulatory Effects of this compound (Selected Findings) |
Immune Cell Population |
Splenic Th1 cells (in mouse model) |
Peripheral blood lymphocytes (CD3+, CD4+, CD57+) (in CRC patients) |
Tumor-infiltrating lymphocytes (TILs) (in CRC patients) |
Neutrophils |
Monocyte-derived DCs (in advanced CRC patients) |
Regulatory/suppressor T cells |
Beyond immunomodulation, research also explores this compound's direct effects on cancer cells and the tumor microenvironment. Methodologies include in vitro cell viability assays (e.g., MTT assay), colony formation assays, and DNA histograms to assess cancer cell proliferation and cell cycle distribution. mdpi.com In vivo studies using tumor-bearing animal models are employed to evaluate the impact of this compound on tumor growth, metastasis, and angiogenesis. nih.govnih.gov Techniques such as immunohistochemistry and Western blotting are used to investigate the expression of proteins involved in cell adhesion (e.g., E-selectin, sialyl Lewis antigens), angiogenesis, and apoptosis.
Research findings suggest that this compound can inhibit cancer cell proliferation, affect histamine metabolism in the tumor microenvironment, block the expression of E-selectin to inhibit cancer cell adhesion and prevent metastasis, and inhibit angiogenesis. mdpi.comnih.govnih.govpharmacytimes.com Studies have shown a correlation between high tumoral levels of sialyl Lewis antigens and a significant survival benefit in colorectal cancer patients treated with this compound, strongly suggesting an effect on cancer cell adhesion. pharmacytimes.com
Non-H2RA Anticancer Effects of this compound (Selected Findings) |
Mechanism |
Cell Proliferation |
Cell Adhesion |
Angiogenesis |
Tumor Microenvironment |
Sialyl Lewis Antigens |
Future directions in the mechanistic elucidation of this compound's non-H2RA effects involve leveraging more advanced technologies. This includes detailed proteomic and transcriptomic analyses to identify the full spectrum of molecular targets and signaling pathways modulated by this compound beyond the H2 receptor. Investigating the interaction of this compound with other receptors and transporters, such as organic cation transporter 2 (OCT2) and equilibrative nucleoside transporter 4 (ENT4), could reveal additional mechanisms of action, particularly concerning drug interactions and potential nephroprotective effects. pharmacytimes.compharmakb.comamazonaws.com Furthermore, the application of systems biology approaches could help integrate the diverse non-H2RA effects of this compound into a comprehensive model, providing a holistic understanding of its complex pharmacological profile and informing future therapeutic strategies. Continued research using well-designed preclinical models and clinical trials with robust mechanistic endpoints is essential to fully unlock the potential of this compound's non-H2RA activities. nih.gov
Q & A
What experimental designs are recommended for studying cimetidine’s antiandrogenic effects in preclinical models?
Answer: Preclinical studies on this compound’s antiandrogenic effects (e.g., gynecomastia, prolactin elevation) should employ multi-group designs with dose-dependent administration. For example, a study using pregnant albino rats divided into control and experimental groups (e.g., 5 g/day vs. lower doses) can assess offspring teratogenicity via behavioral tests like the T-maze . Hormonal assays (prolactin, estradiol) and histopathological analysis of mammary tissue are critical. Note that dose selection must account for species-specific metabolic differences and validate results with human cell lines (e.g., androgen receptor binding assays) .
How can contradictory findings on this compound’s antitumor efficacy be reconciled in gastrointestinal cancer research?
Answer: Discrepancies arise from variations in tumor models and molecular targets. For instance, this compound inhibits E-selectin expression in TNF-α-stimulated endothelial cells (IC₅₀: ~42 nM) via RT-PCR and flow cytometry , but shows no effect on cisplatin cytotoxicity in OCT2-high ovarian cancer cells . Researchers should standardize models (e.g., syngeneic vs. xenograft), validate target engagement (e.g., H2 receptor vs. immune modulation), and use transcriptomic profiling to identify context-dependent pathways .
What methodologies are optimal for analyzing this compound’s pharmacokinetic interactions with CYP450 substrates?
Answer: Use in vitro hepatic microsome assays to quantify CYP450 inhibition (e.g., CYP3A4, CYP2D6) and validate with clinical pharmacokinetic studies. For example, this compound prolongs diazepam half-life by 46% via competitive CYP3A4 inhibition . High-performance liquid chromatography (HPLC) with validated standard curves (e.g., linear range: 0.05–10 µg/mL) ensures precise measurement of drug concentrations in plasma . Physiologically based pharmacokinetic (PBPK) modeling further predicts interactions in populations with renal/hepatic impairment .
How should researchers address this compound’s environmental persistence in ecotoxicology studies?
Answer: this compound’s high soil mobility (Koc = 39) and pH-dependent speciation (pKa = 6.8) necessitate studies using HPLC-UV or LC-MS to quantify photodegradation products . Laser flash photolysis identifies reactive moieties (e.g., imidazole ring oxidation by singlet oxygen, k = 3.3 × 10⁶ M⁻¹s⁻¹ at pH 4) . Field studies in river water should correlate degradation rates with dissolved organic carbon and sunlight intensity .
What statistical approaches resolve conflicting data on this compound’s peri-operative benefits in cancer?
Answer: Meta-analyses of randomized trials (e.g., gastric cancer survival studies ) should apply fixed-effects models to account for heterogeneity in dosing (e.g., 800 mg/day vs. 400 mg/day) and outcome measures (e.g., recurrence vs. metastasis). Subgroup analyses stratified by tumor stage (e.g., TNM classification) and adjuvant therapies (e.g., 5-FU) improve specificity. Bayesian methods can weigh evidence from preclinical (e.g., 3LL cell migration assays ) and clinical datasets .
How can researchers optimize solubility studies for this compound in formulation development?
Answer: Use the NRTL-SAC model in Aspen Properties to predict solubility in mixed solvents (e.g., ethanol-water) . Validate experimentally via UV-vis spectrophotometry (low solubility) or HPLC (high sensitivity) against USP reference standards . Report solubility as mean ± SD with one-way ANOVA and Bonferroni correction for multiple comparisons (α = 0.05) .
What protocols mitigate bias in assessing this compound’s reproductive toxicity?
Answer: Follow OECD guidelines for teratogenicity studies, including blinded histopathology reviews and litter-based analysis to control for maternal effects . Measure fetal serum vitamin B12 (linked to long-term H2 blockade ) and use sham-operated controls to distinguish drug effects from surgical stress. Confounding factors like strain-specific susceptibility (e.g., albino rats vs. C57BL/6 mice) must be documented .
How do OCT2 inhibition assays inform this compound’s role in drug-disease interactions?
Answer: Use HEK293 cells transfected with human OCT2 to quantify inhibition constants (e.g., this compound Ki = 15 µM ). In diabetic rat models, compare metformin pharmacokinetics with/without this compound co-administration, analyzing plasma via LC-MS/MS. PBPK models incorporating renal OCT2 expression levels predict clinical relevance .
Basic vs. Advanced Research Focus
- Basic: Mechanisms (H2 receptor antagonism, CYP450 inhibition), standard PK/PD methods.
- Advanced: Tumor microenvironment modulation, environmental fate, systems pharmacology.
Retrosynthesis Analysis
AI-Powered Synthesis Planning: Our tool employs the Template_relevance Pistachio, Template_relevance Bkms_metabolic, Template_relevance Pistachio_ringbreaker, Template_relevance Reaxys, Template_relevance Reaxys_biocatalysis model, leveraging a vast database of chemical reactions to predict feasible synthetic routes.
One-Step Synthesis Focus: Specifically designed for one-step synthesis, it provides concise and direct routes for your target compounds, streamlining the synthesis process.
Accurate Predictions: Utilizing the extensive PISTACHIO, BKMS_METABOLIC, PISTACHIO_RINGBREAKER, REAXYS, REAXYS_BIOCATALYSIS database, our tool offers high-accuracy predictions, reflecting the latest in chemical research and data.
Strategy Settings
Precursor scoring | Relevance Heuristic |
---|---|
Min. plausibility | 0.01 |
Model | Template_relevance |
Template Set | Pistachio/Bkms_metabolic/Pistachio_ringbreaker/Reaxys/Reaxys_biocatalysis |
Top-N result to add to graph | 6 |
Feasible Synthetic Routes
Featured Recommendations
Most viewed | ||
---|---|---|
Most popular with customers |
Disclaimer and Information on In-Vitro Research Products
Please be aware that all articles and product information presented on BenchChem are intended solely for informational purposes. The products available for purchase on BenchChem are specifically designed for in-vitro studies, which are conducted outside of living organisms. In-vitro studies, derived from the Latin term "in glass," involve experiments performed in controlled laboratory settings using cells or tissues. It is important to note that these products are not categorized as medicines or drugs, and they have not received approval from the FDA for the prevention, treatment, or cure of any medical condition, ailment, or disease. We must emphasize that any form of bodily introduction of these products into humans or animals is strictly prohibited by law. It is essential to adhere to these guidelines to ensure compliance with legal and ethical standards in research and experimentation.